This is a Validated Antibody Database (VAD) review about human CD27, based on 281 published articles (read how Labome selects the articles), using CD27 antibody in all methods. It is aimed to help Labome visitors find the most suited CD27 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD27 synonym: S152; S152. LPFS2; T14; TNFRSF7; Tp55

BioLegend
mouse monoclonal (O323)
  • flow cytometry; human; fig 3g
BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on human samples (fig 3g). J Immunother Cancer (2021) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; 1:200; loading ...
BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on human samples at 1:200. Nature (2021) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; fig 2h
BioLegend CD27 antibody (BioLegend, 302816) was used in flow cytometry on human samples (fig 2h). Cell (2021) ncbi
hamsters monoclonal (LG.3A10)
  • mass cytometry; mouse; loading ...
BioLegend CD27 antibody (BioLegend, 124202) was used in mass cytometry on mouse samples . Br J Cancer (2021) ncbi
mouse monoclonal (O323)
  • mass cytometry; human; loading ...; fig 4e
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD27 antibody (Biolegend, O323) was used in mass cytometry on human samples (fig 4e) and in flow cytometry on human samples (fig 2a). Acta Neuropathol (2021) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD27 antibody (BioLegend, 302828) was used in flow cytometry on human samples (fig 3a). Immunity (2021) ncbi
hamsters monoclonal (LG.3A10)
  • flow cytometry; mouse; loading ...; fig 4e
BioLegend CD27 antibody (Biolegend, 124216) was used in flow cytometry on mouse samples (fig 4e). Cell Rep Med (2021) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; 1:1000; loading ...; fig s1d
BioLegend CD27 antibody (Biolegend, 356417) was used in flow cytometry on human samples at 1:1000 (fig s1d). Cell (2021) ncbi
hamsters monoclonal (LG.3A10)
  • flow cytometry; human; loading ...; fig s2
BioLegend CD27 antibody (BioLegend, LG.3A10) was used in flow cytometry on human samples (fig s2). Aging Cell (2021) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig s5b
BioLegend CD27 antibody (BioLegend, 356418) was used in flow cytometry on human samples (fig s5b). Cell (2021) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...
BioLegend CD27 antibody (BioLegend, 302816) was used in flow cytometry on human samples . J Clin Invest (2020) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig 4a
BioLegend CD27 antibody (BioLegend, M-T271) was used in flow cytometry on human samples (fig 4a). J Clin Invest (2020) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; 1:50; loading ...
BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples at 1:50. Sci Signal (2020) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig 4s1
BioLegend CD27 antibody (Biolegend, 356408) was used in flow cytometry on human samples (fig 4s1). elife (2020) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...
BioLegend CD27 antibody (BioLegend, 356412) was used in flow cytometry on human samples . Nature (2020) ncbi
hamsters monoclonal (LG.3A10)
  • flow cytometry; mouse; 1:200; loading ...; fig 4b
BioLegend CD27 antibody (BioLegend, 124215) was used in flow cytometry on mouse samples at 1:200 (fig 4b). elife (2019) ncbi
hamsters monoclonal (LG.3A10)
  • mass cytometry; mouse; 2.8 ug/ml; loading ...; fig 5d
BioLegend CD27 antibody (Biolegend, LG.3A10) was used in mass cytometry on mouse samples at 2.8 ug/ml (fig 5d). Science (2019) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on human samples (fig s1). Aging Cell (2020) ncbi
hamsters monoclonal (LG.3A10)
  • flow cytometry; mouse; loading ...; fig 5b
BioLegend CD27 antibody (Biolegend, 124210) was used in flow cytometry on mouse samples (fig 5b). Cell (2019) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; 1:50; loading ...; fig s10b
BioLegend CD27 antibody (Biolegend, 302830) was used in flow cytometry on human samples at 1:50 (fig s10b). Science (2019) ncbi
hamsters monoclonal (LG.3A10)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 7a
BioLegend CD27 antibody (Biolegend, 124209) was used in immunohistochemistry - paraffin section on mouse samples (fig 7a). BMC Immunol (2019) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; 1:100; loading ...; fig 3d
BioLegend CD27 antibody (Biolegend, 302827) was used in flow cytometry on human samples at 1:100 (fig 3d). elife (2019) ncbi
mouse monoclonal (O323)
  • other; human; loading ...; fig 4b
BioLegend CD27 antibody (BioLegend, 302847) was used in other on human samples (fig 4b). Cell (2019) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig s3a
BioLegend CD27 antibody (BioLegend, 302816) was used in flow cytometry on human samples (fig s3a). Cell (2019) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples (fig 1a). Front Immunol (2019) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD27 antibody (Biolegend, M-T271) was used in flow cytometry on human samples (fig 1a). Front Immunol (2019) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; 1:100; loading ...; fig 1a
BioLegend CD27 antibody (Biolegend, 356404) was used in flow cytometry on human samples at 1:100 (fig 1a). elife (2019) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on human samples (fig 1a). BMC Res Notes (2019) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples (fig 3a). Arthritis Res Ther (2019) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples (fig 1b). Eur J Immunol (2019) ncbi
hamsters monoclonal (LG.3A10)
  • flow cytometry; human; loading ...; fig s1a
BioLegend CD27 antibody (BioLegend, LG.3A10) was used in flow cytometry on human samples (fig s1a). Aging (Albany NY) (2019) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples (fig 3a). Cell Stem Cell (2019) ncbi
hamsters monoclonal (LG.3A10)
  • flow cytometry; mouse; loading ...; fig 6d
BioLegend CD27 antibody (BioLegend, LG.3A10) was used in flow cytometry on mouse samples (fig 6d). J Immunol (2019) ncbi
hamsters monoclonal (LG.3A10)
  • flow cytometry; mouse; fig 2a
BioLegend CD27 antibody (Biolegend, 124-2C11) was used in flow cytometry on mouse samples (fig 2a). Nature (2019) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 1d
BioLegend CD27 antibody (BioLegend, 302810) was used in flow cytometry on human samples (fig 1d). J Clin Invest (2019) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig 3e
BioLegend CD27 antibody (Biolegend, 356406) was used in flow cytometry on human samples (fig 3e). Cell (2018) ncbi
hamsters monoclonal (LG.3A10)
  • flow cytometry; mouse; loading ...; fig 1c
BioLegend CD27 antibody (BioLegend, lg.3a10) was used in flow cytometry on mouse samples (fig 1c). Front Immunol (2018) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig s4b
BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples (fig s4b). J Clin Invest (2018) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 9a
BioLegend CD27 antibody (Biolegend, 302828) was used in flow cytometry on human samples (fig 9a). J Virol (2018) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig 2c
BioLegend CD27 antibody (BioLegend, M-T271) was used in flow cytometry on human samples (fig 2c). J Immunol (2018) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 1d
BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples (fig 1d). J Immunol (2018) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; 1:50; loading ...; fig 2a
BioLegend CD27 antibody (Biolegend, 356418) was used in flow cytometry on human samples at 1:50 (fig 2a). PLoS ONE (2017) ncbi
mouse monoclonal (M-T271)
  • immunohistochemistry - frozen section; human; loading ...; fig 3a
BioLegend CD27 antibody (BioLegend, 356401) was used in immunohistochemistry - frozen section on human samples (fig 3a). Leukemia (2018) ncbi
mouse monoclonal (O323)
  • mass cytometry; human; loading ...; fig 2a
In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, BioLegend CD27 antibody (BioLegend, O323) was used in mass cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 1d
BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on human samples (fig 1d). Oncotarget (2017) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; fig 1b
In order to investigate the role of long-lived plasma cells in immunity and autoimmunity, BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on human samples (fig 1b). J Immunol (2017) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; fig 1b
BioLegend CD27 antibody (BioLegend, 302814) was used in flow cytometry on human samples (fig 1b). Scand J Immunol (2017) ncbi
hamsters monoclonal (LG.3A10)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend CD27 antibody (Biolegend, LG.3A10) was used in flow cytometry on mouse samples (fig 2a). Eur J Immunol (2017) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD27 antibody (Biolegend, 302808) was used in flow cytometry on human samples (fig 3a). PLoS ONE (2017) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 2b
In order to discuss how mutations in PIK3CD and PIK3R1 cause activated PI3K-delta syndrome, BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples (fig 2b). Clin Immunol (2017) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; 1:100; loading ...; fig s2
BioLegend CD27 antibody (BioLegend, 0323) was used in flow cytometry on human samples at 1:100 (fig s2). JCI Insight (2017) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 1b
In order to show T cell immunoglobulin and ITIM domain expression increases over time despite early initiation of antiretroviral treatment, BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples (fig 1b). Sci Rep (2017) ncbi
mouse monoclonal (O323)
  • flow cytometry; rhesus macaque; loading ...; fig 3a
In order to establish the ability of the herpes simplex virus-1 VC2 vaccine to elicit immune responses in rhesus macaques, BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on rhesus macaque samples (fig 3a). Vaccine (2017) ncbi
mouse monoclonal (O323)
  • blocking or activating experiments; human; 10 ug/ml; loading ...; fig 8a
In order to report the function of CD70-CD27 signaling in patients infected with Epstein-Barr virus, BioLegend CD27 antibody (BioLegend, O323) was used in blocking or activating experiments on human samples at 10 ug/ml (fig 8a). J Exp Med (2017) ncbi
hamsters monoclonal (LG.3A10)
  • flow cytometry; mouse; 1:200; loading ...; fig s1a
In order to find an alternative pathway of NK-cell development driven by IL-12, BioLegend CD27 antibody (BioLegend, LG.3A10) was used in flow cytometry on mouse samples at 1:200 (fig s1a). Nat Commun (2016) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 1e
In order to determine which cells express CD83, BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on human samples (fig 1e). J Immunol (2016) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; fig s4a
In order to study the contribution of T follicular helper cells to islet autoimmunity, BioLegend CD27 antibody (Biolegend, M-T271) was used in flow cytometry on human samples (fig s4a). Proc Natl Acad Sci U S A (2016) ncbi
hamsters monoclonal (LG.3A10)
  • flow cytometry; human; fig 2a
In order to assess the frequencies of liver-infiltrating antibody-secreting B cells in primary biliary cholangitis and primary sclerosing cholangitis, BioLegend CD27 antibody (BioLegend, LG.3A10) was used in flow cytometry on human samples (fig 2a). J Autoimmun (2017) ncbi
hamsters monoclonal (LG.3A10)
  • flow cytometry; mouse; loading ...; fig s4
In order to characterize systemic antimicrobial CD4 positive T cell reactivity, BioLegend CD27 antibody (Biolegend, LG.3A10) was used in flow cytometry on mouse samples (fig s4). Immunology (2017) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 2a
In order to identify and characterize a Nei endonuclease VIII-like 3 mutation in three siblings from a consanguineous family with autoimmunity, BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples (fig 2a). J Clin Invest (2016) ncbi
mouse monoclonal (M-T271)
BioLegend CD27 antibody (Biolegend, 356404) was used . Nat Commun (2016) ncbi
hamsters monoclonal (LG.3A10)
  • flow cytometry; mouse; loading ...; fig 1d
In order to explore signaling pathways regulated by RLTPR in T and B cells, BioLegend CD27 antibody (BioLegend, LG3A10) was used in flow cytometry on mouse samples (fig 1d). J Exp Med (2016) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 3h
BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on human samples (fig 3h). Sci Rep (2016) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 2b
In order to suggest that the BRD4-p300 signaling cascade promotes antitumor T cell grafts that could be used adoptive immunotherapy, BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on human samples (fig 2b). J Clin Invest (2016) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; fig 8
In order to study the promotion of the development of self-reactive T cells by hydrophobic CDR3 residues, BioLegend CD27 antibody (BioLegend, 302830) was used in flow cytometry on human samples (fig 8). Nat Immunol (2016) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; fig 1
BioLegend CD27 antibody (Biolegend, M-T271) was used in flow cytometry on human samples (fig 1). Sci Rep (2016) ncbi
mouse monoclonal (O323)
  • flow cytometry; African green monkey; loading ...; fig 2b
In order to discuss the use of flow cytometry to examine common marmosets, BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on African green monkey samples (fig 2b). J Med Primatol (2016) ncbi
hamsters monoclonal (LG.3A10)
  • flow cytometry; mouse; loading ...; fig 2g
In order to investigate how dopamine receptor D3 signaling affects the balance of effector T cells, BioLegend CD27 antibody (BioLegend, LG.3A10) was used in flow cytometry on mouse samples (fig 2g). J Immunol (2016) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 3
In order to study the pharmacologic inhibition of PI3K and MEK pathways in mixed cultures of human mononuclear cells., BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on human samples (fig 3). Am J Transplant (2016) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human
In order to evaluate the promotion of B cell activation and CXCR4 downregulation by CD161 and LLT1 expression in human germinal centers, BioLegend CD27 antibody (BioLegend, M-T271) was used in flow cytometry on human samples . J Immunol (2016) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 1a
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, BioLegend CD27 antibody (biolegend, O323) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (O323)
  • flow cytometry; rhesus macaque; loading ...; fig 5c
In order to study the CD8+ non-cytolytic antiviral response in SIV infected rhesus macaques, BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on rhesus macaque samples (fig 5c). PLoS ONE (2015) ncbi
hamsters monoclonal (LG.3A10)
  • flow cytometry; mouse; fig 2
BioLegend CD27 antibody (Biolegend, LG-3A10) was used in flow cytometry on mouse samples (fig 2). J Virol (2016) ncbi
hamsters monoclonal (LG.3A10)
  • flow cytometry; human; loading ...; fig s1a
In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, BioLegend CD27 antibody (Biolegend, LG.3A10) was used in flow cytometry on human samples (fig s1a). J Immunol (2015) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; fig 1
In order to assess the CD4/CD8 ratio as a marker for CD4+ T cell dysfunction in chronic HIV infection, BioLegend CD27 antibody (Biolegend, clone O323) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
hamsters monoclonal (LG.3A10)
  • flow cytometry; mouse; loading ...; fig s2
In order to test if anti-retroviral natural killer cell functions are inhibited by T regulatory cells during an acute Friend retrovirus infection, BioLegend CD27 antibody (Biolegend, LG.3A10) was used in flow cytometry on mouse samples (fig s2). Retrovirology (2015) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; fig 4
BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on human samples (fig 4). J Hematol Oncol (2015) ncbi
hamsters monoclonal (LG.3A10)
  • flow cytometry; mouse; fig 3b
BioLegend CD27 antibody (Biolegend, LG.3A10) was used in flow cytometry on mouse samples (fig 3b). J Immunol (2015) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 3c,3f
In order to look at patterns of S. Typhi-specific modulation of the homing potential of circulating Treg in patients with typhoid compared to healthy individuals, BioLegend CD27 antibody (biolegend, 302829) was used in flow cytometry on human samples (fig 3c,3f). PLoS Pathog (2015) ncbi
mouse monoclonal (O323)
  • flow cytometry; human
In order to determine if HIV elite controllers have exhausted T cells, BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples . J Infect Dis (2015) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; fig 1
BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples (fig 1). Int Immunol (2015) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; fig 1
BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples (fig 1). J Infect Dis (2015) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; fig 6
BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples (fig 6). Am J Hum Genet (2015) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; fig 2
BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on human samples (fig 2). J Autoimmun (2015) ncbi
mouse monoclonal (O323)
  • flow cytometry; mouse; 1:100
In order to assess the role of CDH17 in the long-term survival of memory B cells in the bone marrow, BioLegend CD27 antibody (BioLegend, 302805) was used in flow cytometry on mouse samples at 1:100. PLoS ONE (2015) ncbi
hamsters monoclonal (LG.3A10)
  • flow cytometry; mouse; tbl 1
BioLegend CD27 antibody (BioLegend, LG.3A10) was used in flow cytometry on mouse samples (tbl 1). J Neuroinflammation (2015) ncbi
mouse monoclonal (O323)
  • flow cytometry; human
BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples . J Immunol Methods (2015) ncbi
hamsters monoclonal (LG.3A10)
  • flow cytometry; mouse
BioLegend CD27 antibody (Biolegend, L.G.3A10) was used in flow cytometry on mouse samples . Gut (2015) ncbi
hamsters monoclonal (LG.3A10)
  • flow cytometry; mouse; fig 1
BioLegend CD27 antibody (BioLegend, LG.3A10) was used in flow cytometry on mouse samples (fig 1). J Leukoc Biol (2015) ncbi
hamsters monoclonal (LG.3A10)
  • flow cytometry; mouse; loading ...; fig 7c
In order to explore the interaction between IL-2 and IL-7 in CD4 T-cell memory generation, BioLegend CD27 antibody (biolegend, LG.3A10) was used in flow cytometry on mouse samples (fig 7c). Nat Commun (2014) ncbi
mouse monoclonal (O323)
  • flow cytometry; human
In order to identify the role of GammaDelta T cells in acute HIV infection, BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (O323)
  • flow cytometry; human
BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples . Ann Rheum Dis (2015) ncbi
mouse monoclonal (O323)
  • flow cytometry; rhesus macaque
In order to examine the effect of HMBPP-deficient Listeria mutant immunization, BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on rhesus macaque samples . J Leukoc Biol (2014) ncbi
hamsters monoclonal (LG.3A10)
  • flow cytometry; human
BioLegend CD27 antibody (BioLegend, LG.3A10) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (O323)
  • flow cytometry; human
In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BioLegend CD27 antibody (Biolegend, O323) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (O323)
  • flow cytometry; human
BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi
mouse monoclonal (O323)
  • flow cytometry; rhesus macaque
BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on rhesus macaque samples . J Immunol (2014) ncbi
mouse monoclonal (O323)
  • flow cytometry; human
In order to examine human differentiated effector CD4(+) T cells that are defined by low levels of IL-2 and IL-7 receptors, BioLegend CD27 antibody (BioLegend, O323) was used in flow cytometry on human samples . Cancer Res (2014) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 1
In order to discuss the importance of assessing immune competence in cancer patients, BioLegend CD27 antibody (BioLegend, 0323) was used in flow cytometry on human samples (fig 1). Cancer Immunol Immunother (2014) ncbi
Invitrogen
mouse monoclonal (O323)
  • flow cytometry; human; fig s1d
Invitrogen CD27 antibody (eBioscience, 25-0279) was used in flow cytometry on human samples (fig s1d). Cell (2021) ncbi
mouse monoclonal (O323)
  • flow cytometry; mouse; 1:1000; loading ...
Invitrogen CD27 antibody (Thermo Fisher Scientific, 12-0279-42) was used in flow cytometry on mouse samples at 1:1000. Cell Rep Med (2021) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 4d
Invitrogen CD27 antibody (eBioscience, O323) was used in flow cytometry on human samples (fig 4d). Cell Death Dis (2020) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 4a
Invitrogen CD27 antibody (eBioscience, 0323) was used in flow cytometry on human samples (fig 4a). BMC Immunol (2020) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse; 1:400; loading ...; fig s6b
Invitrogen CD27 antibody (eBioscience, 25-0271-82) was used in flow cytometry on mouse samples at 1:400 (fig s6b). Sci Immunol (2020) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; human; loading ...; fig 3g
Invitrogen CD27 antibody (eBioscience, LG.7F9) was used in flow cytometry on human samples (fig 3g). Sci Immunol (2019) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse; loading ...; fig 5b
Invitrogen CD27 antibody (eBioscience, 11-0271-85) was used in flow cytometry on mouse samples (fig 5b). Cell (2019) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig s2b
Invitrogen CD27 antibody (eBioscience, 12-0279-42) was used in flow cytometry on human samples (fig s2b). Cell (2019) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse; loading ...; fig 6a
Invitrogen CD27 antibody (eBioscience, 11-0271-81) was used in flow cytometry on mouse samples (fig 6a). Cell (2019) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse; loading ...; fig 1a
Invitrogen CD27 antibody (eBioscience, LG.7F9) was used in flow cytometry on mouse samples (fig 1a). Nature (2019) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse; 1:200; loading ...; fig 1e
Invitrogen CD27 antibody (eBioscience, 25-0271-8) was used in flow cytometry on mouse samples at 1:200 (fig 1e). Nat Commun (2018) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse; loading ...; fig s3a
Invitrogen CD27 antibody (eBioscience, LG.7F9) was used in flow cytometry on mouse samples (fig s3a). PLoS Pathog (2018) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse; loading ...; fig 3i
Invitrogen CD27 antibody (ebioscience, 14-0271-81) was used in flow cytometry on mouse samples (fig 3i). Cell Rep (2018) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse; 1:300; loading ...; fig s7b
Invitrogen CD27 antibody (eBioscience, LG.7F9) was used in flow cytometry on mouse samples at 1:300 (fig s7b). Nat Commun (2018) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse; loading ...; fig 1e
Invitrogen CD27 antibody (eBioscience, LG.7F9) was used in flow cytometry on mouse samples (fig 1e). Front Immunol (2018) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 2a
Invitrogen CD27 antibody (Ebioscience, 17-0279) was used in flow cytometry on human samples (fig 2a). J Virol (2018) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse; loading ...; fig 1b
Invitrogen CD27 antibody (eBioscience, LG-7F9) was used in flow cytometry on mouse samples (fig 1b). J Exp Med (2018) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse; loading ...; fig 1d
Invitrogen CD27 antibody (eBioscience, LG-7F9) was used in flow cytometry on mouse samples (fig 1d). J Immunol (2018) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse; loading ...; fig 3d
In order to investigate the important of Ly49A ITIM signaling in NK-cell effector inhibition, licensing, and receptor repertoire development, Invitrogen CD27 antibody (eBiosciences, LG.7F9) was used in flow cytometry on mouse samples (fig 3d). Proc Natl Acad Sci U S A (2017) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse; fig s6b
In order to investigate the effect of polymicrobial sepsis in skin immune response, Invitrogen CD27 antibody (eBioscience, LG.7F9) was used in flow cytometry on mouse samples (fig s6b). PLoS Pathog (2017) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; tbl s1
In order to investigate the effect of Shigella infection on human lymphocytes, Invitrogen CD27 antibody (eBioscience, 25-0279-42) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; fig 1a
In order to generate T cells from cord blood hematopoietic progenitor cells transduced to express an antigen receptor as assess their ability to limit malignant cells and graft versus host disease, Invitrogen CD27 antibody (eBioscience, 47-0279-42) was used in flow cytometry on human samples (fig 1a). Oncoimmunology (2017) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig s2
Invitrogen CD27 antibody (eBioscience, 0323) was used in flow cytometry on human samples (fig s2). Oncoimmunology (2017) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse; fig s1b
In order to investigate the mechanisms by which eomesodermin regulates memory fitness in T cells, Invitrogen CD27 antibody (eBioscience, LG.7F9) was used in flow cytometry on mouse samples (fig s1b). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 5
In order to analyze B-cell responses to meningococcal polysaccharide and conjugate vaccines against Neisseria meningitidis, Invitrogen CD27 antibody (eBioscience, 0323) was used in flow cytometry on human samples (fig 5). Genome Med (2017) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse; loading ...
In order to determine that NKG2C/E identifies the CD4 T cell effector subset ThCTL that develop in the lung during influenza A virus infection in mice, Invitrogen CD27 antibody (eBioscience, LG.7F9) was used in flow cytometry on mouse samples . J Immunol (2017) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 7a
In order to investigate the roles of CD16+ monocytes in T-cell activation and B-cell responses in systemic lupus erythematosus, Invitrogen CD27 antibody (eBioscience, 17-0279-42) was used in flow cytometry on human samples (fig 7a). Front Immunol (2016) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 1a
In order to characterize gammadelta T cell subsets from healthy humans, Invitrogen CD27 antibody (ebioscience, O323) was used in flow cytometry on human samples (fig 1a). Proc Natl Acad Sci U S A (2016) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; human; fig 2a
In order to identify a role for CK2 in healthy human thymocytes in the selection of the gamma delta T-cell lineage, Invitrogen CD27 antibody (eBioscience, LG.7F9) was used in flow cytometry on human samples (fig 2a). Leukemia (2017) ncbi
mouse monoclonal (CLB-27/1)
  • flow cytometry; human; loading ...; fig 1a
In order to investigate how differences in B cell populations may contribute to HIV susceptibility, Invitrogen CD27 antibody (Invitrogen, CLB-27/1) was used in flow cytometry on human samples (fig 1a). AIDS Res Hum Retroviruses (2016) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; fig s1
Invitrogen CD27 antibody (eBioscience, O323) was used in flow cytometry on human samples (fig s1). PLoS Pathog (2016) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse; loading ...; fig 2a
In order to elucidate the role of Tbet in acute lung injury, Invitrogen CD27 antibody (eBioscience, LG.7F9) was used in flow cytometry on mouse samples (fig 2a). J Leukoc Biol (2017) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig s1a
In order to compare expression and function of the CD300 family of receptors between neonatal and adult immune cells, Invitrogen CD27 antibody (eBioscience, O323) was used in flow cytometry on human samples (fig s1a). Sci Rep (2016) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse; loading ...; fig 1f, 1g
In order to determine the function of the SLAM family of proteins in natural killer cells, Invitrogen CD27 antibody (eBioscience, LG 7F9) was used in flow cytometry on mouse samples (fig 1f, 1g). J Exp Med (2016) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse; loading ...; fig 4h
In order to demonstrate that the negative regulation of T cell receptor signaling during natural killer T cell development regulates NKT1 and NKT2 differentiation and survival, Invitrogen CD27 antibody (eBioscience, LG.7F9) was used in flow cytometry on mouse samples (fig 4h). J Exp Med (2016) ncbi
mouse monoclonal (O323)
In order to report the composition and temporal dynamics of the Epstein-Barr virus-specific T-cell receptor repertoire in immunocompromised transplant patients, Invitrogen CD27 antibody (eBioscience, 56-0279-42) was used . Immunol Cell Biol (2017) ncbi
mouse monoclonal (CLB-27/1)
  • flow cytometry; human; fig 3
In order to test if CD4 positive T cells expressing immune checkpoint molecules are enriched in HIV-infected cells in patients receiving antiretroviral therapy, Invitrogen CD27 antibody (Invitrogen, Q10066) was used in flow cytometry on human samples (fig 3). PLoS Pathog (2016) ncbi
mouse monoclonal (CLB-27/1)
  • flow cytometry; human; loading ...; fig 2b
In order to characterize B cells and antibody repertoires from injection drug users, Invitrogen CD27 antibody (Invitrogen, CLB-27/1) was used in flow cytometry on human samples (fig 2b). PLoS ONE (2016) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse; loading ...; fig 4a
In order to discover cell-intrinsic division and differentiation differences in neonatal CD8+ T cells, Invitrogen CD27 antibody (eBiosciences, 11-0271-85) was used in flow cytometry on mouse samples (fig 4a). Immunol Cell Biol (2016) ncbi
mouse monoclonal (CLB-27/1)
  • flow cytometry; human; loading ...; fig 2a
In order to develop a method to detect circulating B cells that recognize nuclear antigens in patients, Invitrogen CD27 antibody (Invitrogen, CLB-27/1) was used in flow cytometry on human samples (fig 2a). Arthritis Rheumatol (2016) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; 1:100; fig 7
Invitrogen CD27 antibody (eBioscience, 17-0279) was used in flow cytometry on human samples at 1:100 (fig 7). Haematologica (2016) ncbi
mouse monoclonal (O323)
  • flow cytometry; rhesus macaque; loading ...; fig s3a
Invitrogen CD27 antibody (eBiosciences, O323) was used in flow cytometry on rhesus macaque samples (fig s3a). J Immunol (2016) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 1a
In order to characterize B and T cells from patients with thrombocytopenia, Invitrogen CD27 antibody (eBioscience, 17-0279) was used in flow cytometry on human samples (fig 1a). Haematologica (2016) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; fig s5
Invitrogen CD27 antibody (eBioscience, 12-0279) was used in flow cytometry on human samples (fig s5). Nat Biotechnol (2016) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse; 1:200; fig s4
In order to assess the role of NLRC5 to NK-T-cell crosstalk, Invitrogen CD27 antibody (eBioscience, LG.7F9) was used in flow cytometry on mouse samples at 1:200 (fig s4). Nat Commun (2016) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; fig 5
Invitrogen CD27 antibody (eBioscience, 0323) was used in flow cytometry on human samples (fig 5). Sci Rep (2016) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse
In order to study dendritic cells in Sirt6 knock out mice, Invitrogen CD27 antibody (Ebioscience, LG.7F9) was used in flow cytometry on mouse samples . Aging (Albany NY) (2016) ncbi
mouse monoclonal (CLB-27/1)
  • flow cytometry; human; fig 1
In order to analyze HIV progression traits of a selective loss of early differentiated and highly functional PD1high CD4 T cells, Invitrogen CD27 antibody (Invitrogen, CLB-27/1) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse; fig 3
In order to study how DNAM-1 controls NK cell-mediated cytotoxicity and cytokine production, Invitrogen CD27 antibody (eBioscience, LG 7F9) was used in flow cytometry on mouse samples (fig 3). J Exp Med (2015) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; human; 10 ug/ml
In order to utilize mass cytometry for multiplexed peptide-MHC tetramer staining, Invitrogen CD27 antibody (eBioscience, LG.7F9) was used in flow cytometry on human samples at 10 ug/ml. Methods Mol Biol (2015) ncbi
mouse monoclonal (CLB-27/1)
  • flow cytometry; human
In order to assess the role of B cells in tolerant kidney transplant recipients, Invitrogen CD27 antibody (Invitrogen, CLB-27/1) was used in flow cytometry on human samples . Am J Transplant (2015) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse
In order to study PI3Kdelta in CD8+ T cells during infection with Listeria monocytogenes, Invitrogen CD27 antibody (eBioscience, Lg.7F9) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
mouse monoclonal (O323)
  • flow cytometry; mouse; fig 4
In order to compare the initial systemic Env-specific B cell responses of AGMs and rhesus macaques, Invitrogen CD27 antibody (eBioscience, O323) was used in flow cytometry on mouse samples (fig 4). J Virol (2015) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; fig 5
Invitrogen CD27 antibody (eBioscience, O323) was used in flow cytometry on human samples (fig 5). J Exp Med (2015) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse; fig 5
Invitrogen CD27 antibody (eBioscience, LG.7F9) was used in flow cytometry on mouse samples (fig 5). Nat Immunol (2015) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; human; fig 1
In order to describe the phenotype and functional potential of metastatic differentiated thyroid cancer-associated PD-1 positive T cells, Invitrogen CD27 antibody (eBioscience, LG.7F9) was used in flow cytometry on human samples (fig 1). Cancer Immunol Res (2015) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse; fig 6
Invitrogen CD27 antibody (eBioscience, LG.7F9) was used in flow cytometry on mouse samples (fig 6). PLoS Pathog (2015) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; human; fig 3
Invitrogen CD27 antibody (eBioscience, LG7F9) was used in flow cytometry on human samples (fig 3). Blood (2015) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse
In order to assess the effects of Hspa9 haploinsufficiency on hematopoiesis using zebrafish, Invitrogen CD27 antibody (eBioscience, LG.7F9) was used in flow cytometry on mouse samples . Exp Hematol (2015) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse
Invitrogen CD27 antibody (eBioscience, LG.7F9) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
mouse monoclonal (O323)
  • flow cytometry; human
Invitrogen CD27 antibody (eBioscience, O323) was used in flow cytometry on human samples . J Allergy Clin Immunol (2015) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; tbl 2
In order to test if flow cytometry can be used to find mantle cell lymphoma, Invitrogen CD27 antibody (eBioscience, O323) was used in flow cytometry on human samples (tbl 2). Cytometry B Clin Cytom (2014) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse; fig 3
Invitrogen CD27 antibody (eBioscience, LG.7F9) was used in flow cytometry on mouse samples (fig 3). J Immunol (2015) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 2f
In order to discuss the therapeutic use of ex vivo-generated Akt-inhibited minor histocompatibility antigen-specific CD8+ T cells, Invitrogen CD27 antibody (eBioscience, O323) was used in flow cytometry on human samples (fig 2f). Blood (2014) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse
Invitrogen CD27 antibody (eBioscience, LG.7F9) was used in flow cytometry on mouse samples . Eur J Immunol (2014) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; human; 1:50
Invitrogen CD27 antibody (eBioscience, LG.7F9) was used in flow cytometry on human samples at 1:50. Nat Commun (2014) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse
Invitrogen CD27 antibody (eBioscience, LG.7F9) was used in flow cytometry on mouse samples . Sci Rep (2014) ncbi
mouse monoclonal (O323)
  • flow cytometry; rhesus macaque
Invitrogen CD27 antibody (eBioscience, O323) was used in flow cytometry on rhesus macaque samples . Clin Immunol (2014) ncbi
mouse monoclonal (O323)
  • flow cytometry; human
Invitrogen CD27 antibody (eBiosciences, O323) was used in flow cytometry on human samples . J Clin Immunol (2014) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse
In order to study the modulation of CD4 T-cell senescence and cytokine production and the roles played by Menin and Bach2, Invitrogen CD27 antibody (eBioscience, LG.7F9) was used in flow cytometry on mouse samples . Nat Commun (2014) ncbi
mouse monoclonal (O323)
  • flow cytometry; human
Invitrogen CD27 antibody (eBioscience, O323) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi
mouse monoclonal (CLB-27/1)
  • flow cytometry; human; 1:50; fig s6
In order to decipher how susequent acute infection is supressed in T cell responses after exposure to subinfectious hepatitis C virus, Invitrogen CD27 antibody (Invitrogen, CLB-27/1) was used in flow cytometry on human samples at 1:50 (fig s6). Nat Med (2013) ncbi
mouse monoclonal (CLB-27/1)
  • flow cytometry; human
In order to elucidate phenotypical and functional characteristics of cytomegalovirus-specific CD8(+) T cells in chronic lymphocytic leukemia patients, Invitrogen CD27 antibody (Invitrogen, noca) was used in flow cytometry on human samples . Blood (2014) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse; fig 3
Invitrogen CD27 antibody (eBioscience, LG.7F9) was used in flow cytometry on mouse samples (fig 3). PLoS ONE (2013) ncbi
mouse monoclonal (CLB-27/1)
  • immunocytochemistry; human; fig 1
In order to assess the effect of immunosuppression used for organ transplantation on immune responses to adeno-associated virus capsid antigens, Invitrogen CD27 antibody (Invitrogen, clone CLB-27/1) was used in immunocytochemistry on human samples (fig 1). Hum Gene Ther (2013) ncbi
mouse monoclonal (O323)
  • flow cytometry; African green monkey; loading ...; fig s3b
In order to investigate mucosal dysfunction in relation to HIV/SIV pathogenesis, Invitrogen CD27 antibody (eBioscience, O323) was used in flow cytometry on African green monkey samples (fig s3b). J Immunol (2013) ncbi
mouse monoclonal (CLB-27/1)
  • flow cytometry; human; fig 3
In order to investigate the CSK polymorphism rs34933034 in B cells and lupus, Invitrogen CD27 antibody (Invitrogen, MHCD2704) was used in flow cytometry on human samples (fig 3). Nat Genet (2012) ncbi
mouse monoclonal (CLB-27/1)
  • flow cytometry; human; fig 2
In order to assess the breakdown of tolerance in HIV patients, Invitrogen CD27 antibody (Invitrogen, CLB-27/1) was used in flow cytometry on human samples (fig 2). PLoS ONE (2012) ncbi
mouse monoclonal (CLB-27/1)
  • flow cytometry; human; fig 3, 5
In order to test if B cell responses to antigen were compromised in rheumatoid arthritis patients treated with anti-TNF therapy, Invitrogen CD27 antibody (Invitrogen, CLB-27/1) was used in flow cytometry on human samples (fig 3, 5). Arthritis Res Ther (2011) ncbi
mouse monoclonal (O323)
  • flow cytometry; human
In order to determine the role for DOCK8 in peripheral CD8 T cell survival and function, Invitrogen CD27 antibody (eBioscience, O323) was used in flow cytometry on human samples . J Exp Med (2011) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; loading ...; fig 5a
In order to elucidate relationships among MAPK pathway function, HIV-1-induced activation, and exhaustion markers in circulating CD8+ T cells, Invitrogen CD27 antibody (eBiosciences, O323) was used in flow cytometry on human samples (fig 5a). J Virol (2011) ncbi
mouse monoclonal (CLB-27/1)
  • flow cytometry; human; fig 1
In order to test if rejection of AAV-transduced hepatocytes is due to AAV capsid-specific CD8 positive T cells that become reactivated upon gene transfer, Invitrogen CD27 antibody (Invitrogen, clone CLB-27/1) was used in flow cytometry on human samples (fig 1). Mol Ther (2011) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; tbl 3
In order to study Vgamma2Vdelta2 T cells from Caucasian or African American donors, Invitrogen CD27 antibody (eBioscience, O323) was used in flow cytometry on human samples (tbl 3). Hum Immunol (2010) ncbi
mouse monoclonal (CLB-27/1)
  • flow cytometry; human; fig 3
In order to show that surface IL-17A is a marker for Th17 cells, Invitrogen CD27 antibody (Caltag, MHCD2727) was used in flow cytometry on human samples (fig 3). J Immunol (2009) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; 1:100; fig 2
In order to show that suberoylanilide hydroxamic acid reactivates HIV from latency in chronically infected cell lines and primary cells, Invitrogen CD27 antibody (eBioscience, 0323) was used in flow cytometry on human samples at 1:100 (fig 2). J Biol Chem (2009) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; fig 1
In order to study Vgamma2Vdelta2 T cells in HIV infected patients, Invitrogen CD27 antibody (eBioscience, 0323) was used in flow cytometry on human samples (fig 1). J Leukoc Biol (2008) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse
In order to analyze protection against Plasmodium berghei by a single-dose simian adenovirus vector using a human cytomegalovirus promoter containing intron A, Invitrogen CD27 antibody (eBioscience, LG.7F9) was used in flow cytometry on mouse samples . J Virol (2008) ncbi
hamsters monoclonal (LG.7F9)
  • flow cytometry; mouse; fig 2
Invitrogen CD27 antibody (eBioscience, LG.7F9) was used in flow cytometry on mouse samples (fig 2). J Immunol (2007) ncbi
mouse monoclonal (O323)
  • flow cytometry; human
In order to discuss the frequency and contribution of CD27- memory B cells to systemic lupus erythematosus, Invitrogen CD27 antibody (eBioscience, O323) was used in flow cytometry on human samples . J Immunol (2007) ncbi
mouse monoclonal (O323)
  • flow cytometry; human; fig 7
In order to characterize the regulation and expression of the orphan receptor RDC1 and its putative ligand in human B and dendritic cells, Invitrogen CD27 antibody (eBioscience, O323) was used in flow cytometry on human samples (fig 7). J Immunol (2006) ncbi
mouse monoclonal (CLB-27/1)
  • flow cytometry; human
In order to show that T cell expansion and contractions in persistent viral infections is not limited to the acute phase of infection, but continues in latent infection, Invitrogen CD27 antibody (Caltag, CLB-27/1) was used in flow cytometry on human samples . Eur J Immunol (2005) ncbi
mouse monoclonal (O323)
  • flow cytometry; human
In order to assess if T regulatory cells modulate infiltrating T lymphocytes in human metastatic melanoma, Invitrogen CD27 antibody (eBioscience, O323) was used in flow cytometry on human samples . J Immunol (2004) ncbi
mouse monoclonal (LT27)
  • blocking or activating experiments; human
In order to investigate galectin-1 in T cells, Invitrogen CD27 antibody (Caltag, LT27) was used in blocking or activating experiments on human samples . J Immunol (1999) ncbi
Abcam
domestic rabbit monoclonal (EPR8569)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 1c
Abcam CD27 antibody (Abcam, ab131254) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1c). Nat Commun (2019) ncbi
mouse monoclonal (LT27)
  • flow cytometry; human; 1:100; loading ...; fig S5a
In order to discuss cell type accountable for parvovirus B19 DNA tissue persistence, Abcam CD27 antibody (Abcam, ab30366) was used in flow cytometry on human samples at 1:100 (fig S5a). Nat Commun (2017) ncbi
Miltenyi Biotec
human monoclonal (REA499)
  • flow cytometry; human; loading ...; fig 1h
Miltenyi Biotec CD27 antibody (Miltenyi Biotec, REA499) was used in flow cytometry on human samples (fig 1h). J Autoimmun (2018) ncbi
human monoclonal (REA499)
  • flow cytometry; human; fig 3f
Miltenyi Biotec CD27 antibody (Miltenyi Biotec, REA499) was used in flow cytometry on human samples (fig 3f). N Biotechnol (2018) ncbi
Santa Cruz Biotechnology
mouse monoclonal (B-8)
  • western blot; human; loading ...; fig 3d
Santa Cruz Biotechnology CD27 antibody (Santa Cruz Biotechnology, sc-25289) was used in western blot on human samples (fig 3d). Oncotarget (2017) ncbi
Bio-Rad
mouse monoclonal (LT27)
  • flow cytometry; human; loading ...; fig 1a
In order to investigate the role of long-lived plasma cells in immunity and autoimmunity, Bio-Rad CD27 antibody (AbD Serotec, LT27) was used in flow cytometry on human samples (fig 1a). J Immunol (2017) ncbi
Beckman Coulter
mouse monoclonal (1A4CD27)
  • flow cytometry; human; loading ...; fig s8a
Beckman Coulter CD27 antibody (Beckman Coulter, 1A4CD27) was used in flow cytometry on human samples (fig s8a). Nat Commun (2020) ncbi
mouse monoclonal (1A4CD27)
  • flow cytometry; human; loading ...; fig s2
Beckman Coulter CD27 antibody (Immunotech, 1A4CD27) was used in flow cytometry on human samples (fig s2). Front Immunol (2019) ncbi
mouse monoclonal (1A4CD27)
  • flow cytometry; human; tbl 3
In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, Beckman Coulter CD27 antibody (Beckman Coulter (Immunotech), 1A4-CD27) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi
mouse monoclonal (1A4CD27)
  • flow cytometry; human; 1:25; fig 2
Beckman Coulter CD27 antibody (Beckman Coulter, 1A4CD27) was used in flow cytometry on human samples at 1:25 (fig 2). Nat Commun (2016) ncbi
mouse monoclonal (1A4CD27)
  • flow cytometry; human; loading ...; fig st1
Beckman Coulter CD27 antibody (Beckman Coulter, A54823) was used in flow cytometry on human samples (fig st1). PLoS ONE (2016) ncbi
mouse monoclonal (1A4CD27)
  • flow cytometry; human; tbl 1
Beckman Coulter CD27 antibody (Beckman Coulter, 826607107) was used in flow cytometry on human samples (tbl 1). Oncoimmunology (2016) ncbi
mouse monoclonal (1A4CD27)
  • flow cytometry; human; fig 1a
In order to analyze HIV progression traits of a selective loss of early differentiated and highly functional PD1high CD4 T cells, Beckman Coulter CD27 antibody (Beckman Coulter, IA4CD27) was used in flow cytometry on human samples (fig 1a). PLoS ONE (2015) ncbi
mouse monoclonal (1A4CD27)
  • flow cytometry; human
Beckman Coulter CD27 antibody (Beckman Coulter, A54823) was used in flow cytometry on human samples . Arthritis Res Ther (2015) ncbi
mouse monoclonal (1A4CD27)
  • flow cytometry; human; tbl s4
In order to examine the early impact of viral replicative capacity on HIV-1 immunopathogenesis, Beckman Coulter CD27 antibody (Beckman Coulter, 1A4CD27) was used in flow cytometry on human samples (tbl s4). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (1A4CD27)
  • flow cytometry; human; fig 1
Beckman Coulter CD27 antibody (beckman Coulter, 14CD27) was used in flow cytometry on human samples (fig 1). Stem Cell Res Ther (2015) ncbi
mouse monoclonal (1A4CD27)
  • flow cytometry; human
In order to report the immune responses elicited in an outpatient Phase 2 clinical trial in which subjects were vaccinated with CVD 1208S (DeltaguaBA, Deltaset, Deltasen S. flexneri 2a), Beckman Coulter CD27 antibody (Beckman-Coulter, 1A4CD27) was used in flow cytometry on human samples . Front Immunol (2014) ncbi
mouse monoclonal (1A4CD27)
  • flow cytometry; human
Beckman Coulter CD27 antibody (Beckman Coulter, clone 1A4CD27) was used in flow cytometry on human samples . Mol Ther (2014) ncbi
BD Biosciences
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig s2a
BD Biosciences CD27 antibody (BD, M-T271) was used in flow cytometry on human samples (fig s2a). Arthritis Res Ther (2021) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...
BD Biosciences CD27 antibody (BD, M-T271) was used in flow cytometry on human samples . Adv Sci (Weinh) (2021) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig 5a
BD Biosciences CD27 antibody (BD Biosciences, 562513) was used in flow cytometry on human samples (fig 5a). J Clin Invest (2021) ncbi
mouse monoclonal (L128)
  • flow cytometry; human; loading ...
BD Biosciences CD27 antibody (BD Biosciences, 340425) was used in flow cytometry on human samples . Cell (2021) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; African green monkey; fig s2
BD Biosciences CD27 antibody (BD biosciences, 555441) was used in flow cytometry on African green monkey samples (fig s2). Cell (2021) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; 1:200; loading ...; fig s2a
BD Biosciences CD27 antibody (BD Biosciences, M-T271) was used in flow cytometry on human samples at 1:200 (fig s2a). Nature (2021) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; fig 3b
BD Biosciences CD27 antibody (BD Biosciences, 562297) was used in flow cytometry on human samples (fig 3b). elife (2020) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig s1
BD Biosciences CD27 antibody (BD Biosciences, 560985) was used in flow cytometry on human samples (fig s1). Cell (2020) ncbi
mouse monoclonal (L128)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD27 antibody (BD Biosciences, L128) was used in flow cytometry on human samples (fig 2a). Science (2020) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences CD27 antibody (BD Biosciences, 560985) was used in flow cytometry on human samples (fig 1b). Cell (2020) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig 5d
BD Biosciences CD27 antibody (BD Bioscience, 560611) was used in flow cytometry on human samples (fig 5d). Stem Cell Res Ther (2020) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig s10b
BD Biosciences CD27 antibody (BD Biosciences, 562513) was used in flow cytometry on human samples (fig s10b). Nat Commun (2019) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD27 antibody (BD Biosciences, 555440) was used in flow cytometry on human samples (fig 1a). Nat Commun (2019) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig s3c
BD Biosciences CD27 antibody (BD, 560612) was used in flow cytometry on human samples (fig s3c). Cell (2019) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; 1:100; loading ...; fig 1a
BD Biosciences CD27 antibody (eBioscience, 560222) was used in flow cytometry on human samples at 1:100 (fig 1a). elife (2019) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig 7a
BD Biosciences CD27 antibody (BD Horizon, 562513) was used in flow cytometry on human samples (fig 7a). Front Immunol (2019) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig s7d
BD Biosciences CD27 antibody (BD Biosciences, 555441) was used in flow cytometry on human samples (fig s7d). Mol Cell (2019) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig s3b
BD Biosciences CD27 antibody (BD Biosciences, 555441) was used in flow cytometry on human samples (fig s3b). Nat Immunol (2018) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig s1a
BD Biosciences CD27 antibody (Becton Dickinson, 555440) was used in flow cytometry on human samples (fig s1a). J Clin Invest (2018) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig 2
BD Biosciences CD27 antibody (BD Pharmigen, M-T271) was used in flow cytometry on human samples (fig 2). Arthritis Res Ther (2018) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD27 antibody (BD Biosciences, 555440) was used in flow cytometry on human samples (fig 3a). Oncotarget (2018) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig 4a
BD Biosciences CD27 antibody (BD Biosciences, M-T271) was used in flow cytometry on human samples (fig 4a). Oncotarget (2018) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig 2
BD Biosciences CD27 antibody (BD, M-T271) was used in flow cytometry on human samples (fig 2). Biol Blood Marrow Transplant (2018) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; 1:20; fig s2
BD Biosciences CD27 antibody (BD, M-T271) was used in flow cytometry on human samples at 1:20 (fig s2). Nat Commun (2017) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human
In order to investigate the role of dopamine in B cell maturation in germinal centres, BD Biosciences CD27 antibody (BD Biosciences, M-T271) was used in flow cytometry on human samples . Nature (2017) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig st1
BD Biosciences CD27 antibody (BD, MT-271) was used in flow cytometry on human samples (fig st1). J Exp Med (2017) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig s2
BD Biosciences CD27 antibody (BD Pharmingen, 555441) was used in flow cytometry on human samples (fig s2). Scand J Immunol (2017) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig s3d
In order to report that autosomal recessive, partial Go-Ichi-Ni-San 1 deficiency impairs DNA replication and underlies intra-uterine and postnatal growth retardation, chronic neutropenia, and natural killer cell deficiency, BD Biosciences CD27 antibody (BD, M-T271) was used in flow cytometry on human samples (fig s3d). J Clin Invest (2017) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; rhesus macaque; loading ...; fig s16b
BD Biosciences CD27 antibody (BD Biosciences, M-T271) was used in flow cytometry on rhesus macaque samples (fig s16b). JCI Insight (2017) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig s1e
In order to use CD49a expression to define subsets of tissue-resident memory T cells in the skin, BD Biosciences CD27 antibody (BD Bioscience, M-T271) was used in flow cytometry on human samples (fig s1e). Immunity (2017) ncbi
mouse monoclonal (L128)
  • flow cytometry; human; loading ...; fig 3e
BD Biosciences CD27 antibody (BD Biosciences, 340425) was used in flow cytometry on human samples (fig 3e). Oncoimmunology (2016) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig s3a
BD Biosciences CD27 antibody (BD, M-T271) was used in flow cytometry on human samples (fig s3a). JCI Insight (2017) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD27 antibody (BD Biosciences, 555440) was used in flow cytometry on human samples (fig 3a). Oncoimmunology (2016) ncbi
mouse monoclonal (L128)
  • flow cytometry; human; loading ...
In order to discuss how mutations in PIK3CD and PIK3R1 cause activated PI3K-delta syndrome, BD Biosciences CD27 antibody (BD Biosciences, L128) was used in flow cytometry on human samples . Clin Immunol (2017) ncbi
mouse monoclonal (L128)
  • flow cytometry; human; loading ...
In order to develop a functional assay to assess the risk of developing acute graft-versus-host disease, BD Biosciences CD27 antibody (BD Biosciences, L128) was used in flow cytometry on human samples . J Immunol Res (2016) ncbi
mouse monoclonal (L128)
  • flow cytometry; human; loading ...; fig s1b
In order to describe complete autosomal recessive IL-17RA deficiency in patients with chronic mucocutaneous candidiasis, BD Biosciences CD27 antibody (BD Biosciences, L128) was used in flow cytometry on human samples (fig s1b). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; tbl 3
BD Biosciences CD27 antibody (BD Pharmingen, M-T271) was used in flow cytometry on human samples (tbl 3). Brain Behav (2016) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; rhesus macaque; loading ...; fig s7c
In order to assess the efficacy of targeting alpha4 beta7 integrin to treat SIV, BD Biosciences CD27 antibody (BD Pharmingen, 555440) was used in flow cytometry on rhesus macaque samples (fig s7c). Science (2016) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig 1a, s2f
In order to discuss targeting CD123 to treat systemic lupus erythematosus, BD Biosciences CD27 antibody (BD Biosciences, 561222) was used in flow cytometry on human samples (fig 1a, s2f). JCI Insight (2016) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig 5
BD Biosciences CD27 antibody (Becton Dickinson, M-T271) was used in flow cytometry on human samples (fig 5). PLoS ONE (2016) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig 3a
In order to investigate the contribution of the PD-1 pathway in allogeneic stem cell transplantation, BD Biosciences CD27 antibody (BD Biosciences, M-T271) was used in flow cytometry on human samples (fig 3a). Biol Blood Marrow Transplant (2016) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig 4b
In order to report the composition and temporal dynamics of the Epstein-Barr virus-specific T-cell receptor repertoire in immunocompromised transplant patients, BD Biosciences CD27 antibody (BD Biosciences, 558664) was used in flow cytometry on human samples (fig 4b). Immunol Cell Biol (2017) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig s2d
BD Biosciences CD27 antibody (BD, M-T271) was used in flow cytometry on human samples (fig s2d). J Clin Invest (2016) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; mouse; loading ...; fig st1
BD Biosciences CD27 antibody (BD Pharmingen, M-T271) was used in flow cytometry on mouse samples (fig st1). J Clin Invest (2016) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; African green monkey; loading ...; fig 2b
In order to discuss the use of flow cytometry to examine common marmosets, BD Biosciences CD27 antibody (BD, M-T271) was used in flow cytometry on African green monkey samples (fig 2b). J Med Primatol (2016) ncbi
mouse monoclonal (L128)
  • flow cytometry; human; loading ...
In order to test if the two hematopoietic systems in patients with mixed chimerism remain functional and study immunological differences, BD Biosciences CD27 antibody (BD Biosciences, L128) was used in flow cytometry on human samples . PLoS ONE (2016) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; fig 2
BD Biosciences CD27 antibody (BD, M-T271) was used in flow cytometry on human samples (fig 2). JCI Insight (2016) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig s2
In order to discover that T follicular helper cells preferentially express the transcriptional coactivator Bob1, BD Biosciences CD27 antibody (BD Biosciences, M-T271) was used in flow cytometry on human samples (fig s2). Eur J Immunol (2016) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD27 antibody (BD Biosciences, M-T271) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; baboons; fig 5
In order to analyze how chimeric 2C10R4 anti-CD40 antibody therapy is essential for long-term survival of pig-to-primate cardiac xenograft (GTKO.hCD46.hTBM), BD Biosciences CD27 antibody (Pharmingen, 557329) was used in flow cytometry on baboons samples (fig 5). Nat Commun (2016) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences CD27 antibody (BD, 555441) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; fig 1
BD Biosciences CD27 antibody (BD Biosciences, M-T271) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2016) ncbi
mouse monoclonal (L128)
  • flow cytometry; human; loading ...; fig 7a
BD Biosciences CD27 antibody (Becton Dickinson, 337169) was used in flow cytometry on human samples (fig 7a). BMC Biotechnol (2016) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...
In order to elucidate the role of TfR1 in adaptive immunity, BD Biosciences CD27 antibody (BD Biosciences, M-T271) was used in flow cytometry on human samples . Nat Genet (2016) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; fig 2
BD Biosciences CD27 antibody (BD Biosciences, 555440) was used in flow cytometry on human samples (fig 2). MAbs (2016) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig 3a
In order to assess the efficacy of a single vaccination of the Yellow Fever vaccine, BD Biosciences CD27 antibody (BD PharMingen, M-T271) was used in flow cytometry on human samples (fig 3a). Hum Vaccin Immunother (2016) ncbi
mouse monoclonal (L128)
  • flow cytometry; human; fig 1
BD Biosciences CD27 antibody (BD Biosciences, 337169) was used in flow cytometry on human samples (fig 1). Arthritis Res Ther (2015) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; fig 3a
BD Biosciences CD27 antibody (BD Biosciences, M-T271) was used in flow cytometry on human samples (fig 3a). PLoS Negl Trop Dis (2015) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; tbl 1
In order to compare the use of CD229, CD54, and CD319 expression for the identification of normal and aberrant plasma cells, BD Biosciences CD27 antibody (BD, M-T271) was used in flow cytometry on human samples (tbl 1). Cytometry B Clin Cytom (2016) ncbi
mouse monoclonal (L128)
  • flow cytometry; human; fig 2
In order to characterize gut-associated gammadelta T-cells in HIV-infected individuals, BD Biosciences CD27 antibody (BD Biosciences, L128) was used in flow cytometry on human samples (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; fig 1
BD Biosciences CD27 antibody (BD Bioscience, 560612) was used in flow cytometry on human samples (fig 1). J Hematol Oncol (2015) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig 5a
BD Biosciences CD27 antibody (BD Biosciences, M-T271) was used in flow cytometry on human samples (fig 5a). Ann Rheum Dis (2016) ncbi
mouse monoclonal (L128)
  • flow cytometry; human; fig 5
In order to examine the antibody repertoire of patients with acute systemic lupus erythematosus, BD Biosciences CD27 antibody (BD Pharmingen, L128) was used in flow cytometry on human samples (fig 5). Nat Immunol (2015) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human
BD Biosciences CD27 antibody (BD Pharmingen, 555441) was used in flow cytometry on human samples . Arthritis Res Ther (2015) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; tbl s1
BD Biosciences CD27 antibody (BD Biosciences, M-T271) was used in flow cytometry on human samples (tbl s1). PLoS ONE (2015) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human
In order to discuss the use of stem cells to treat Wiskott-Aldrich syndrome, BD Biosciences CD27 antibody (BD, M-T271) was used in flow cytometry on human samples . J Allergy Clin Immunol (2015) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; tbl s1
In order to examine the early impact of viral replicative capacity on HIV-1 immunopathogenesis, BD Biosciences CD27 antibody (BD Biosciences, MT271) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; tbl s5
In order to investigate when Vgamma9Vdelta2 T cells develop, BD Biosciences CD27 antibody (BD Bioscience, M-T271) was used in flow cytometry on human samples (tbl s5). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human
BD Biosciences CD27 antibody (BD Pharmingen, M-T271) was used in flow cytometry on human samples . Clin Cancer Res (2015) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human
BD Biosciences CD27 antibody (BD, M-T271) was used in flow cytometry on human samples . Eur J Cancer (2015) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human
BD Biosciences CD27 antibody (BD, M-T271) was used in flow cytometry on human samples . Nat Commun (2014) ncbi
mouse monoclonal (L128)
  • flow cytometry; human
BD Biosciences CD27 antibody (BD, L128) was used in flow cytometry on human samples . Nat Commun (2014) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; rhesus macaque
BD Biosciences CD27 antibody (BD Biosciences, M-T271) was used in flow cytometry on rhesus macaque samples . J Leukoc Biol (2015) ncbi
mouse monoclonal (L128)
  • flow cytometry; human
BD Biosciences CD27 antibody (BD Bioscience, L128) was used in flow cytometry on human samples . J Hepatol (2015) ncbi
mouse monoclonal (L128)
  • flow cytometry; human; 10 ul per test
BD Biosciences CD27 antibody (BD Biosciences, L128) was used in flow cytometry on human samples at 10 ul per test. Cytometry B Clin Cytom (2014) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human
BD Biosciences CD27 antibody (BD, M-T271) was used in flow cytometry on human samples . Eur J Immunol (2014) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human
BD Biosciences CD27 antibody (BD Biosciences, M-T271) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (L128)
  • flow cytometry; human; loading ...; fig 4a
BD Biosciences CD27 antibody (BD Biosciences, L128) was used in flow cytometry on human samples (fig 4a). J Immunol (2014) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human
BD Biosciences CD27 antibody (BD PharMingen, 560609) was used in flow cytometry on human samples . Eur J Immunol (2014) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human
BD Biosciences CD27 antibody (BD Bioscience, M-T271) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (L128)
  • flow cytometry; human; loading ...; fig 1a
In order to investigate the effects of lymphopenia and chronic exposure to IFN on T cell homeostasis, BD Biosciences CD27 antibody (BD Biosciences, L128) was used in flow cytometry on human samples (fig 1a). PLoS Pathog (2014) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human
BD Biosciences CD27 antibody (BD, M-T271) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (L128)
  • flow cytometry; human; tbl 1
In order to examine the changes in erythrocytes and T-lymphocytes and to explore the mechanisms involved in stress-induced depression using a rat depression model, BD Biosciences CD27 antibody (BD Bio-sciences, clone L128) was used in flow cytometry on human samples (tbl 1). Environ Toxicol Pharmacol (2014) ncbi
mouse monoclonal (M-T271)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD27 antibody (Becton Dickinson, M-T271) was used in flow cytometry on human samples (fig 1a). Clin Immunol (2014) ncbi
mouse monoclonal (L128)
  • flow cytometry; human; loading ...
In order to assess the effect of delayed administration of the BCG vaccine on the induced immune response in Ugandan children, BD Biosciences CD27 antibody (BD Biosciences, L128) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi
Articles Reviewed
  1. Reijm S, Kissel T, Stoeken Rijsbergen G, Slot L, Wortel C, van Dooren H, et al. Cross-reactivity of IgM anti-modified protein antibodies in rheumatoid arthritis despite limited mutational load. Arthritis Res Ther. 2021;23:230 pubmed publisher
  2. Dalla Pietà A, Cappuzzello E, Palmerini P, Ventura A, Visentin A, Astori G, et al. Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells. J Immunother Cancer. 2021;9: pubmed publisher
  3. Li D, Edwards R, Manne K, Martinez D, Schäfer A, Alam S, et al. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies. Cell. 2021;184:4203-4219.e32 pubmed publisher
  4. Li N, Torres M, Spetz M, Wang R, Peng L, Tian M, et al. CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice. Cell Rep Med. 2021;2:100297 pubmed publisher
  5. Bohannon C, Ende Z, Cao W, Mboko W, Ranjan P, Kumar A, et al. Influenza Virus Infects and Depletes Activated Adaptive Immune Responders. Adv Sci (Weinh). 2021;8:e2100693 pubmed publisher
  6. Barker K, Etesami N, Shenoy A, Arafa E, Lyon de Ana C, Smith N, et al. Lung-resident memory B cells protect against bacterial pneumonia. J Clin Invest. 2021;131: pubmed publisher
  7. Turner J, Kim W, Kalaidina E, Goss C, Rauseo A, Schmitz A, et al. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Nature. 2021;595:421-425 pubmed publisher
  8. Williams W, Meyerhoff R, Edwards R, Li H, Manne K, Nicely N, et al. Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies. Cell. 2021;184:2955-2972.e25 pubmed publisher
  9. Joseph R, Soundararajan R, Vasaikar S, Yang F, Allton K, Tian L, et al. CD8+ T cells inhibit metastasis and CXCL4 regulates its function. Br J Cancer. 2021;125:176-189 pubmed publisher
  10. Ingelfinger F, Krishnarajah S, Kramer M, Utz S, Galli E, Lutz M, et al. Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature. Acta Neuropathol. 2021;141:901-915 pubmed publisher
  11. Szabo P, Dogra P, Gray J, Wells S, Connors T, Weisberg S, et al. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity. 2021;54:797-814.e6 pubmed publisher
  12. Bonilla W, Kirchhammer N, Marx A, Kallert S, Krzyzaniak M, Lu M, et al. Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attack. Cell Rep Med. 2021;2:100209 pubmed publisher
  13. Andreano E, Nicastri E, Paciello I, Pileri P, Manganaro N, Piccini G, et al. Extremely potent human monoclonal antibodies from COVID-19 convalescent patients. Cell. 2021;184:1821-1835.e16 pubmed publisher
  14. Brouwer P, Brinkkemper M, Maisonnasse P, Dereuddre Bosquet N, Grobben M, Claireaux M, et al. Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection. Cell. 2021;184:1188-1200.e19 pubmed publisher
  15. Sokal A, Chappert P, Barba Spaeth G, Roeser A, Fourati S, Azzaoui I, et al. Maturation and persistence of the anti-SARS-CoV-2 memory B cell response. Cell. 2021;184:1201-1213.e14 pubmed publisher
  16. Biswas S, Mandal G, Payne K, Anadon C, Gatenbee C, Chaurio R, et al. IgA transcytosis and antigen recognition govern ovarian cancer immunity. Nature. 2021;591:464-470 pubmed publisher
  17. Webb L, Fra Bido S, Innocentin S, Matheson L, Attaf N, Bignon A, et al. Ageing promotes early T follicular helper cell differentiation by modulating expression of RBPJ. Aging Cell. 2021;20:e13295 pubmed publisher
  18. Rodda L, Netland J, Shehata L, Pruner K, Morawski P, Thouvenel C, et al. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19. Cell. 2021;184:169-183.e17 pubmed publisher
  19. Luo B, Zhan Y, Luo M, Dong H, Liu J, Lin Y, et al. Engineering of α-PD-1 antibody-expressing long-lived plasma cells by CRISPR/Cas9-mediated targeted gene integration. Cell Death Dis. 2020;11:973 pubmed publisher
  20. Neidleman J, Luo X, Frouard J, Xie G, Hsiao F, Ma T, et al. Phenotypic analysis of the unstimulated in vivo HIV CD4 T cell reservoir. elife. 2020;9: pubmed publisher
  21. Tan E, Hopkins R, Lim C, Jamuar S, Ong C, Thoon K, et al. Dominant-negative NFKBIA mutation promotes IL-1β production causing hepatic disease with severe immunodeficiency. J Clin Invest. 2020;130:5817-5832 pubmed publisher
  22. Kreer C, Zehner M, Weber T, Ercanoglu M, Gieselmann L, Rohde C, et al. Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients. Cell. 2020;: pubmed publisher
  23. Brouwer P, Caniels T, van der Straten K, Snitselaar J, Aldon Y, Bangaru S, et al. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science. 2020;369:643-650 pubmed publisher
  24. Kuhny M, Forbes L, Çakan E, Vega Loza A, Kostiuk V, Dinesh R, et al. Disease-associated CTNNBL1 mutation impairs somatic hypermutation by decreasing nuclear AID. J Clin Invest. 2020;: pubmed publisher
  25. Zurli V, Montecchi T, Heilig R, Poschke I, Volkmar M, Wimmer G, et al. Phosphoproteomics of CD2 signaling reveals AMPK-dependent regulation of lytic granule polarization in cytotoxic T cells. Sci Signal. 2020;13: pubmed publisher
  26. Liu G, Yu Y, Feng F, Zhu P, Zhang H, Zhang D, et al. Human CD8+CD28- T suppressor cells expanded by common gamma chain (γc) cytokines retain steady allospecific suppressive capacity in vivo. BMC Immunol. 2020;21:23 pubmed publisher
  27. Pallikkuth S, Chaudhury S, Lu P, Pan L, Jongert E, Wille Reece U, et al. A delayed fractionated dose RTS,S AS01 vaccine regimen mediates protection via improved T follicular helper and B cell responses. elife. 2020;9: pubmed publisher
  28. Schommers P, Gruell H, Abernathy M, Tran M, Dingens A, Gristick H, et al. Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody. Cell. 2020;180:471-489.e22 pubmed publisher
  29. Schafflick D, Xu C, Hartlehnert M, Cole M, Schulte Mecklenbeck A, Lautwein T, et al. Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. Nat Commun. 2020;11:247 pubmed publisher
  30. Asrat S, Kaur N, Liu X, Ben L, Kajimura D, Murphy A, et al. Chronic allergen exposure drives accumulation of long-lived IgE plasma cells in the bone marrow, giving rise to serological memory. Sci Immunol. 2020;5: pubmed publisher
  31. Gate D, Saligrama N, Leventhal O, Yang A, Unger M, Middeldorp J, et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease. Nature. 2020;577:399-404 pubmed publisher
  32. Queckborner S, Syk Lundberg E, Gemzell Danielsson K, Davies L. Endometrial stromal cells exhibit a distinct phenotypic and immunomodulatory profile. Stem Cell Res Ther. 2020;11:15 pubmed publisher
  33. Jimeno R, Lebrusant Fernandez M, Margreitter C, LUCAS B, Veerapen N, Kelly G, et al. Tissue-specific shaping of the TCR repertoire and antigen specificity of iNKT cells. elife. 2019;8: pubmed publisher
  34. Guo C, Allen B, Hiam K, Dodd D, Van Treuren W, Higginbottom S, et al. Depletion of microbiome-derived molecules in the host using Clostridium genetics. Science. 2019;366: pubmed publisher
  35. Callender L, Carroll E, Bober E, Akbar A, Solito E, Henson S. Mitochondrial mass governs the extent of human T cell senescence. Aging Cell. 2020;19:e13067 pubmed publisher
  36. Sanz Ortega L, Rojas J, Portilla Y, Pérez Yagüe S, Barber D. Magnetic Nanoparticles Attached to the NK Cell Surface for Tumor Targeting in Adoptive Transfer Therapies Does Not Affect Cellular Effector Functions. Front Immunol. 2019;10:2073 pubmed publisher
  37. Griss J, Bauer W, Wagner C, Simon M, Chen M, Grabmeier Pfistershammer K, et al. B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma. Nat Commun. 2019;10:4186 pubmed publisher
  38. Dong M, Wang G, Chow R, Ye L, Zhu L, Dai X, et al. Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells. Cell. 2019;178:1189-1204.e23 pubmed publisher
  39. Serra Peinado C, Grau Expósito J, Luque Ballesteros L, Astorga Gamaza A, Navarro J, Gallego Rodriguez J, et al. Expression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab. Nat Commun. 2019;10:3705 pubmed publisher
  40. Crank M, Ruckwardt T, Chen M, Morabito K, Phung E, Costner P, et al. A proof of concept for structure-based vaccine design targeting RSV in humans. Science. 2019;365:505-509 pubmed publisher
  41. Xiong Y, Cheng S, Wu X, Ren Y, Xie X. Changes of B cell subsets in central pathological process of autoimmune encephalomyelitis in mice. BMC Immunol. 2019;20:24 pubmed publisher
  42. Burel J, Pomaznoy M, Lindestam Arlehamn C, Weiskopf D, da Silva Antunes R, Jung Y, et al. Circulating T cell-monocyte complexes are markers of immune perturbations. elife. 2019;8: pubmed publisher
  43. Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck W, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;: pubmed publisher
  44. Ahmed R, Omidian Z, Giwa A, Cornwell B, Majety N, Bell D, et al. A Public BCR Present in a Unique Dual-Receptor-Expressing Lymphocyte from Type 1 Diabetes Patients Encodes a Potent T Cell Autoantigen. Cell. 2019;177:1583-1599.e16 pubmed publisher
  45. Staniek J, Lorenzetti R, Heller B, Janowska I, Schneider P, Unger S, et al. TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes. Front Immunol. 2019;10:951 pubmed publisher
  46. Davis C, Jackson K, McElroy A, Halfmann P, Huang J, Chennareddy C, et al. Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection. Cell. 2019;: pubmed publisher
  47. Moffett H, Harms C, Fitzpatrick K, Tooley M, Boonyaratanakornkit J, Taylor J. B cells engineered to express pathogen-specific antibodies protect against infection. Sci Immunol. 2019;4: pubmed publisher
  48. Zumaquero E, Stone S, Scharer C, Jenks S, Nellore A, Mousseau B, et al. IFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation. elife. 2019;8: pubmed publisher
  49. Zimmermann M, Rose N, Lindner J, Kim H, Gonçalves A, Callegari I, et al. Antigen Extraction and B Cell Activation Enable Identification of Rare Membrane Antigen Specific Human B Cells. Front Immunol. 2019;10:829 pubmed publisher
  50. Terahara K, Iwabuchi R, Hosokawa M, Nishikawa Y, Takeyama H, Takahashi Y, et al. A CCR5+ memory subset within HIV-1-infected primary resting CD4+ T cells is permissive for replication-competent, latently infected viruses in vitro. BMC Res Notes. 2019;12:242 pubmed publisher
  51. Ye Y, Liu M, Tang L, Du F, Liu Y, Hao P, et al. Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis. Arthritis Res Ther. 2019;21:92 pubmed publisher
  52. Lee S, Mayr C. Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. Mol Cell. 2019;: pubmed publisher
  53. Remmerswaal E, Hombrink P, Nota B, Pircher H, ten Berge I, van Lier R, et al. Expression of IL-7Rα and KLRG1 defines functionally distinct CD8+ T-cell populations in humans. Eur J Immunol. 2019;49:694-708 pubmed publisher
  54. Jin C, Lagoudas G, Zhao C, Bullman S, Bhutkar A, Hu B, et al. Commensal Microbiota Promote Lung Cancer Development via γδ T Cells. Cell. 2019;176:998-1013.e16 pubmed publisher
  55. Muller Durovic B, Grählert J, Devine O, Akbar A, Hess C. CD56-negative NK cells with impaired effector function expand in CMV and EBV co-infected healthy donors with age. Aging (Albany NY). 2019;11:724-740 pubmed publisher
  56. Montel Hagen A, Seet C, Li S, Chick B, Zhu Y, Chang P, et al. Organoid-Induced Differentiation of Conventional T Cells from Human Pluripotent Stem Cells. Cell Stem Cell. 2019;24:376-389.e8 pubmed publisher
  57. McLaren J, Clement M, Marsden M, Miners K, Llewellyn Lacey S, Grant E, et al. IL-33 Augments Virus-Specific Memory T Cell Inflation and Potentiates the Efficacy of an Attenuated Cytomegalovirus-Based Vaccine. J Immunol. 2019;202:943-955 pubmed publisher
  58. Collins P, Cella M, Porter S, Li S, Gurewitz G, Hong H, et al. Gene Regulatory Programs Conferring Phenotypic Identities to Human NK Cells. Cell. 2019;176:348-360.e12 pubmed publisher
  59. Karmaus P, Chen X, Lim S, Herrada A, Nguyen T, Xu B, et al. Metabolic heterogeneity underlies reciprocal fates of TH17 cell stemness and plasticity. Nature. 2019;565:101-105 pubmed publisher
  60. Ishizuka J, Manguso R, Cheruiyot C, Bi K, Panda A, Iracheta Vellve A, et al. Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade. Nature. 2019;565:43-48 pubmed publisher
  61. Bouafia A, Lofek S, Bruneau J, Chentout L, Lamrini H, Trinquand A, et al. Loss of ARHGEF1 causes a human primary antibody deficiency. J Clin Invest. 2019;129:1047-1060 pubmed publisher
  62. Wang F, Meng M, Mo B, Yang Y, Ji Y, Huang P, et al. Crosstalks between mTORC1 and mTORC2 variagate cytokine signaling to control NK maturation and effector function. Nat Commun. 2018;9:4874 pubmed publisher
  63. Jensen I, Winborn C, Fosdick M, Shao P, Tremblay M, Shan Q, et al. Polymicrobial sepsis influences NK-cell-mediated immunity by diminishing NK-cell-intrinsic receptor-mediated effector responses to viral ligands or infections. PLoS Pathog. 2018;14:e1007405 pubmed publisher
  64. Jelcić I, Al Nimer F, Wang J, Lentsch V, Planas R, Jelcic I, et al. Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis. Cell. 2018;175:85-100.e23 pubmed publisher
  65. Geary C, Krishna C, Lau C, Adams N, Gearty S, Pritykin Y, et al. Non-redundant ISGF3 Components Promote NK Cell Survival in an Auto-regulatory Manner during Viral Infection. Cell Rep. 2018;24:1949-1957.e6 pubmed publisher
  66. Kong X, Martinez Barricarte R, Kennedy J, Mele F, Lazarov T, Deenick E, et al. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol. 2018;19:973-985 pubmed publisher
  67. Nguyen X, Dauvilliers Y, Quériault C, Pérals C, Romieu Mourez R, Paulet P, et al. Circulating follicular helper T cells exhibit reduced ICOS expression and impaired function in narcolepsy type 1 patients. J Autoimmun. 2018;94:134-142 pubmed publisher
  68. Zhu L, Xie X, Zhang L, Wang H, Jie Z, Zhou X, et al. TBK-binding protein 1 regulates IL-15-induced autophagy and NKT cell survival. Nat Commun. 2018;9:2812 pubmed publisher
  69. Abel A, Tiwari A, Gerbec Z, Siebert J, Yang C, Schloemer N, et al. IQ Domain-Containing GTPase-Activating Protein 1 Regulates Cytoskeletal Reorganization and Facilitates NKG2D-Mediated Mechanistic Target of Rapamycin Complex 1 Activation and Cytokine Gene Translation in Natural Killer Cells. Front Immunol. 2018;9:1168 pubmed publisher
  70. Weniger M, Tiacci E, Schneider S, Arnolds J, Rüschenbaum S, Duppach J, et al. Human CD30+ B cells represent a unique subset related to Hodgkin lymphoma cells. J Clin Invest. 2018;128:2996-3007 pubmed publisher
  71. Armas González E, Domínguez Luis M, Díaz Martín A, Arce Franco M, Castro Hernandez J, Danelon G, et al. Role of CXCL13 and CCL20 in the recruitment of B cells to inflammatory foci in chronic arthritis. Arthritis Res Ther. 2018;20:114 pubmed publisher
  72. Ferrara F, Kolnik M, D Angelo S, Erasmus F, Vorholt D, Bradbury A. Rapid purification of billions of circulating CD19+ B cells directly from leukophoresis samples. N Biotechnol. 2018;46:14-21 pubmed publisher
  73. Yao Y, Huang W, Li X, Li X, Qian J, Han H, et al. Tespa1 Deficiency Dampens Thymus-Dependent B-Cell Activation and Attenuates Collagen-Induced Arthritis in Mice. Front Immunol. 2018;9:965 pubmed publisher
  74. Yeo L, Woodwyk A, Sood S, Lorenc A, Eichmann M, Pujol Autonell I, et al. Autoreactive T effector memory differentiation mirrors β cell function in type 1 diabetes. J Clin Invest. 2018;128:3460-3474 pubmed publisher
  75. Sullivan N, Reuter Monslow M, Sei J, Durr E, Davis C, Chang C, et al. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans. J Virol. 2018;92: pubmed publisher
  76. Shi Y, Zhang P, Wang G, Liu X, Sun X, Zhang X, et al. Description of organ-specific phenotype, and functional characteristics of tissue resident lymphocytes from liver transplantation donor and research on immune tolerance mechanism of liver. Oncotarget. 2018;9:15552-15565 pubmed publisher
  77. Jegaskanda S, Mason R, Andrews S, Wheatley A, Zhang R, Reynoso G, et al. Intranasal Live Influenza Vaccine Priming Elicits Localized B Cell Responses in Mediastinal Lymph Nodes. J Virol. 2018;92: pubmed publisher
  78. Omilusik K, Nadjsombati M, Shaw L, Yu B, Milner J, Goldrath A. Sustained Id2 regulation of E proteins is required for terminal differentiation of effector CD8+ T cells. J Exp Med. 2018;215:773-783 pubmed publisher
  79. Han S, Yang S, Jo H, Oh Y, Park M, Kim J, et al. BAFF and APRIL expression as an autoimmune signature of membranous nephropathy. Oncotarget. 2018;9:3292-3302 pubmed publisher
  80. Pugh J, Nemat Gorgani N, Norman P, Guethlein L, Parham P. Human NK Cells Downregulate Zap70 and Syk in Response to Prolonged Activation or DNA Damage. J Immunol. 2018;200:1146-1158 pubmed publisher
  81. Ibitokou S, Dillon B, Sinha M, Szczesny B, Delgadillo A, Reda Abdelrahman D, et al. Early Inhibition of Fatty Acid Synthesis Reduces Generation of Memory Precursor Effector T Cells in Chronic Infection. J Immunol. 2018;200:643-656 pubmed publisher
  82. Amodio D, Cotugno N, Macchiarulo G, Rocca S, Dimopoulos Y, Castrucci M, et al. Quantitative Multiplexed Imaging Analysis Reveals a Strong Association between Immunogen-Specific B Cell Responses and Tonsillar Germinal Center Immune Dynamics in Children after Influenza Vaccination. J Immunol. 2018;200:538-550 pubmed publisher
  83. Hutten T, Norde W, Woestenenk R, Wang R, Maas F, Kester M, et al. Increased Coexpression of PD-1, TIGIT, and KLRG-1 on Tumor-Reactive CD8+ T Cells During Relapse after Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2018;24:666-677 pubmed publisher
  84. Arthur Huang K, Chen M, Huang Y, Shih S, Chiu C, Lin J, et al. Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children. Nat Commun. 2017;8:762 pubmed publisher
  85. Bern M, Beckman D, Ebihara T, Taffner S, Poursine Laurent J, White J, et al. Immunoreceptor tyrosine-based inhibitory motif-dependent functions of an MHC class I-specific NK cell receptor. Proc Natl Acad Sci U S A. 2017;114:E8440-E8447 pubmed publisher
  86. Danahy D, Anthony S, Jensen I, Hartwig S, Shan Q, Xue H, et al. Polymicrobial sepsis impairs bystander recruitment of effector cells to infected skin despite optimal sensing and alarming function of skin resident memory CD8 T cells. PLoS Pathog. 2017;13:e1006569 pubmed publisher
  87. Pinaud L, Samassa F, Porat Z, Ferrari M, Belotserkovsky I, Parsot C, et al. Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of Shigella toward human lymphocytes. Proc Natl Acad Sci U S A. 2017;114:9954-9959 pubmed publisher
  88. Svensson A, Patzi Churqui M, Schlüter K, Lind L, Eriksson K. Maturation-dependent expression of AIM2 in human B-cells. PLoS ONE. 2017;12:e0183268 pubmed publisher
  89. Klymenko T, Bloehdorn J, Bahlo J, Robrecht S, Akylzhanova G, Cox K, et al. Lamin B1 regulates somatic mutations and progression of B-cell malignancies. Leukemia. 2018;32:364-375 pubmed publisher
  90. Papa I, Saliba D, Ponzoni M, Bustamante S, Canete P, Gonzalez Figueroa P, et al. TFH-derived dopamine accelerates productive synapses in germinal centres. Nature. 2017;547:318-323 pubmed publisher
  91. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed publisher
  92. Domae E, Hirai Y, Ikeo T, Goda S, Shimizu Y. Cytokine-mediated activation of human ex vivo-expanded V?9V?2 T cells. Oncotarget. 2017;8:45928-45942 pubmed publisher
  93. Arumugakani G, Stephenson S, Newton D, Rawstron A, Emery P, Doody G, et al. Early Emergence of CD19-Negative Human Antibody-Secreting Cells at the Plasmablast to Plasma Cell Transition. J Immunol. 2017;198:4618-4628 pubmed publisher
  94. Cerboni S, Jeremiah N, Gentili M, Gehrmann U, Conrad C, Stolzenberg M, et al. Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes. J Exp Med. 2017;214:1769-1785 pubmed publisher
  95. Pérez Martínez C, Maravillas Montero J, Meza Herrera I, Vences Catalan F, Zlotnik A, Santos Argumedo L. Tspan33 is Expressed in Transitional and Memory B Cells, but is not Responsible for High ADAM10 Expression. Scand J Immunol. 2017;86:23-30 pubmed publisher
  96. Cottineau J, Kottemann M, Lach F, Kang Y, Vély F, Deenick E, et al. Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. J Clin Invest. 2017;127:1991-2006 pubmed publisher
  97. Van Caeneghem Y, De Munter S, Tieppo P, Goetgeluk G, Weening K, Verstichel G, et al. Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacities. Oncoimmunology. 2017;6:e1283460 pubmed publisher
  98. Lino C, Barros Martins J, Oberdörfer L, Walzer T, Prinz I. Eomes expression reports the progressive differentiation of IFN-?-producing Th1-like ?? T cells. Eur J Immunol. 2017;47:970-981 pubmed publisher
  99. Kaczmarek D, Kokordelis P, Kramer B, Glässner A, Wolter F, Goeser F, et al. Alterations of the NK cell pool in HIV/HCV co-infection. PLoS ONE. 2017;12:e0174465 pubmed publisher
  100. Pyöriä L, Toppinen M, Mäntylä E, Hedman L, Aaltonen L, Vihinen Ranta M, et al. Extinct type of human parvovirus B19 persists in tonsillar B cells. Nat Commun. 2017;8:14930 pubmed publisher
  101. Dowling D, van Haren S, Scheid A, Bergelson I, Kim D, Mancuso C, et al. TLR7/8 adjuvant overcomes newborn hyporesponsiveness to pneumococcal conjugate vaccine at birth. JCI Insight. 2017;2:e91020 pubmed publisher
  102. Cheuk S, Schlums H, Gallais Sérézal I, Martini E, Chiang S, Marquardt N, et al. CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin. Immunity. 2017;46:287-300 pubmed publisher
  103. Su S, Zou Z, Chen F, Ding N, Du J, Shao J, et al. CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer. Oncoimmunology. 2017;6:e1249558 pubmed publisher
  104. Knudson K, Pritzl C, Saxena V, Altman A, Daniels M, Teixeiro E. NFκB-Pim-1-Eomesodermin axis is critical for maintaining CD8 T-cell memory quality. Proc Natl Acad Sci U S A. 2017;114:E1659-E1667 pubmed publisher
  105. Watanabe N, Bajgain P, Sukumaran S, Ansari S, Heslop H, Rooney C, et al. Fine-tuning the CAR spacer improves T-cell potency. Oncoimmunology. 2016;5:e1253656 pubmed publisher
  106. Martin Gayo E, Cronin J, Hickman T, Ouyang Z, Lindqvist M, Kolb K, et al. Circulating CXCR5+CXCR3+PD-1lo Tfh-like cells in HIV-1 controllers with neutralizing antibody breadth. JCI Insight. 2017;2:e89574 pubmed publisher
  107. O CONNOR D, Clutterbuck E, Thompson A, Snape M, Ramasamy M, Kelly D, et al. High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine. Genome Med. 2017;9:11 pubmed publisher
  108. Parrot T, Oger R, Benlalam H, Raingeard de la Blétière D, Jouand N, Coutolleau A, et al. CD40L confers helper functions to human intra-melanoma class-I-restricted CD4+CD8+ double positive T cells. Oncoimmunology. 2016;5:e1250991 pubmed publisher
  109. Wentink M, Dalm V, Lankester A, van Schouwenburg P, Schölvinck L, Kalina T, et al. Genetic defects in PI3K? affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections. Clin Immunol. 2017;176:77-86 pubmed publisher
  110. Raposo R, de Mulder Rougvie M, Paquin Proulx D, Brailey P, Cabido V, Zdinak P, et al. IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis. JCI Insight. 2017;2:e85811 pubmed publisher
  111. Tauriainen J, Scharf L, Frederiksen J, Naji A, Ljunggren H, Sonnerborg A, et al. Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals. Sci Rep. 2017;7:40354 pubmed publisher
  112. Ren H, Liu F, Huang G, Liu Y, Shen J, Zhou P, et al. Positive feedback loop of IL-1β/Akt/RARα/Akt signaling mediates oncogenic property of RARα in gastric carcinoma. Oncotarget. 2017;8:6718-6729 pubmed publisher
  113. Marshall N, Vong A, Devarajan P, Brauner M, Kuang Y, Nayar R, et al. NKG2C/E Marks the Unique Cytotoxic CD4 T Cell Subset, ThCTL, Generated by Influenza Infection. J Immunol. 2017;198:1142-1155 pubmed publisher
  114. Stanfield B, Pahar B, Chouljenko V, Veazey R, Kousoulas K. Vaccination of rhesus macaques with the live-attenuated HSV-1 vaccine VC2 stimulates the proliferation of mucosal T cells and germinal center responses resulting in sustained production of highly neutralizing antibodies. Vaccine. 2017;35:536-543 pubmed publisher
  115. Izawa K, Martin E, Soudais C, Bruneau J, Boutboul D, Rodriguez R, et al. Inherited CD70 deficiency in humans reveals a critical role for the CD70-CD27 pathway in immunity to Epstein-Barr virus infection. J Exp Med. 2017;214:73-89 pubmed publisher
  116. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed publisher
  117. Ohs I, Van Den Broek M, Nussbaum K, MUNZ C, Arnold S, Quezada S, et al. Interleukin-12 bypasses common gamma-chain signalling in emergency natural killer cell lymphopoiesis. Nat Commun. 2016;7:13708 pubmed publisher
  118. Sairafi D, Stikvoort A, Gertow J, Mattsson J, Uhlin M. Donor Cell Composition and Reactivity Predict Risk of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. J Immunol Res. 2016;2016:5601204 pubmed
  119. Lévy R, Okada S, Béziat V, Moriya K, Liu C, Chai L, et al. Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency. Proc Natl Acad Sci U S A. 2016;113:E8277-E8285 pubmed publisher
  120. Zhu H, Hu F, Sun X, Zhang X, Zhu L, Liu X, et al. CD16+ Monocyte Subset Was Enriched and Functionally Exacerbated in Driving T-Cell Activation and B-Cell Response in Systemic Lupus Erythematosus. Front Immunol. 2016;7:512 pubmed
  121. Ryan P, Sumaria N, Holland C, Bradford C, Izotova N, Grandjean C, et al. Heterogeneous yet stable Vδ2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals. Proc Natl Acad Sci U S A. 2016;113:14378-14383 pubmed
  122. Ribeiro S, Tesio M, Ribot J, Macintyre E, Barata J, Silva Santos B. Casein kinase 2 controls the survival of normal thymic and leukemic ?? T cells via promotion of AKT signaling. Leukemia. 2017;31:1603-1610 pubmed publisher
  123. Ju X, Silveira P, Hsu W, Elgundi Z, Alingcastre R, Verma N, et al. The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population. J Immunol. 2016;197:4613-4625 pubmed
  124. Serr I, Fürst R, Ott V, Scherm M, Nikolaev A, Gökmen F, et al. miRNA92a targets KLF2 and the phosphatase PTEN signaling to promote human T follicular helper precursors in T1D islet autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6659-E6668 pubmed
  125. Chung B, Guevel B, Reynolds G, Gupta Udatha D, Henriksen E, Stamataki Z, et al. Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis. J Autoimmun. 2017;77:45-54 pubmed publisher
  126. Dyer W, Tan J, Day T, Kiers L, Kiernan M, Yiannikas C, et al. Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy. Brain Behav. 2016;6:e00516 pubmed
  127. Kwong Chung C, Ronchi F, Geuking M. Detrimental effect of systemic antimicrobial CD4+ T-cell reactivity on gut epithelial integrity. Immunology. 2017;150:221-235 pubmed publisher
  128. Massaad M, Zhou J, Tsuchimoto D, Chou J, Jabara H, Janssen E, et al. Deficiency of base excision repair enzyme NEIL3 drives increased predisposition to autoimmunity. J Clin Invest. 2016;126:4219-4236 pubmed publisher
  129. Byrareddy S, Arthos J, Cicala C, Villinger F, Ortiz K, Little D, et al. Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy. Science. 2016;354:197-202 pubmed
  130. Oon S, Huynh H, Tai T, Ng M, Monaghan K, Biondo M, et al. A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus. JCI Insight. 2016;1:e86131 pubmed publisher
  131. Alivernini S, Kurowska Stolarska M, Tolusso B, Benvenuto R, Elmesmari A, Canestri S, et al. MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis. Nat Commun. 2016;7:12970 pubmed publisher
  132. Clavarino G, Delouche N, Vettier C, Laurin D, Pernollet M, Raskovalova T, et al. Novel Strategy for Phenotypic Characterization of Human B Lymphocytes from Precursors to Effector Cells by Flow Cytometry. PLoS ONE. 2016;11:e0162209 pubmed publisher
  133. Roncagalli R, Cucchetti M, Jarmuzynski N, Gregoire C, Bergot E, Audebert S, et al. The scaffolding function of the RLTPR protein explains its essential role for CD28 co-stimulation in mouse and human T cells. J Exp Med. 2016;213:2437-2457 pubmed
  134. Keefer M, Zheng B, Rosenberg A, Kobie J. Increased Steady-State Memory B Cell Subsets Among High-Risk Participants in an HIV Vaccine Trial. AIDS Res Hum Retroviruses. 2016;32:1143-1148 pubmed
  135. Pachnio A, Ciáurriz M, Begum J, Lal N, Zuo J, Beggs A, et al. Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium. PLoS Pathog. 2016;12:e1005832 pubmed publisher
  136. Hoegl S, Ehrentraut H, Brodsky K, Victorino F, Golden Mason L, Eltzschig H, et al. NK cells regulate CXCR2+ neutrophil recruitment during acute lung injury. J Leukoc Biol. 2017;101:471-480 pubmed publisher
  137. Zenarruzabeitia O, Vitallé J, Garcia Obregon S, Astigarraga I, Eguizabal C, Santos S, et al. The expression and function of human CD300 receptors on blood circulating mononuclear cells are distinct in neonates and adults. Sci Rep. 2016;6:32693 pubmed publisher
  138. Jiang J, Chen X, An H, Yang B, Zhang F, Cheng X. Enhanced immune response of MAIT cells in tuberculous pleural effusions depends on cytokine signaling. Sci Rep. 2016;6:32320 pubmed publisher
  139. Guo H, Cranert S, Lu Y, Zhong M, Zhang S, Chen J, et al. Deletion of Slam locus in mice reveals inhibitory role of SLAM family in NK cell responses regulated by cytokines and LFA-1. J Exp Med. 2016;213:2187-207 pubmed publisher
  140. Toro J, Salgado D, Vega R, Rodríguez J, Rodríguez L, Angel J, et al. Total and Envelope Protein-Specific Antibody-Secreting Cell Response in Pediatric Dengue Is Highly Modulated by Age and Subsequent Infections. PLoS ONE. 2016;11:e0161795 pubmed publisher
  141. Drennan M, Govindarajan S, Verheugen E, Coquet J, Staal J, McGuire C, et al. NKT sublineage specification and survival requires the ubiquitin-modifying enzyme TNFAIP3/A20. J Exp Med. 2016;213:1973-81 pubmed publisher
  142. Kagoya Y, Nakatsugawa M, Yamashita Y, Ochi T, Guo T, Anczurowski M, et al. BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models. J Clin Invest. 2016;126:3479-94 pubmed publisher
  143. Schade H, Sen S, Neff C, Freed B, Gao D, Gutman J, et al. Programmed Death 1 Expression on CD4+ T Cells Predicts Mortality after Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2016;22:2172-2179 pubmed publisher
  144. Nguyen T, Bird N, Grant E, Miles J, Thomas P, Kotsimbos T, et al. Maintenance of the EBV-specific CD8+ TCR?? repertoire in immunosuppressed lung transplant recipients. Immunol Cell Biol. 2017;95:77-86 pubmed publisher
  145. Franzese O, Palermo B, Di Donna C, Sperduti I, Ferraresi V, Stabile H, et al. Polyfunctional Melan-A-specific tumor-reactive CD8(+) T cells elicited by dacarbazine treatment before peptide-vaccination depends on AKT activation sustained by ICOS. Oncoimmunology. 2016;5:e1114203 pubmed publisher
  146. Fromentin R, Bakeman W, Lawani M, Khoury G, Hartogensis W, DaFonseca S, et al. CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART. PLoS Pathog. 2016;12:e1005761 pubmed publisher
  147. Piepenbrink M, Samuel M, Zheng B, Carter B, Fucile C, Bunce C, et al. Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users. PLoS ONE. 2016;11:e0158641 pubmed publisher
  148. Stadinski B, Shekhar K, Gomez Tourino I, Jung J, Sasaki K, Sewell A, et al. Hydrophobic CDR3 residues promote the development of self-reactive T cells. Nat Immunol. 2016;17:946-55 pubmed publisher
  149. Xu Y, Chaudhury A, Zhang M, Savoldo B, Metelitsa L, Rodgers J, et al. Glycolysis determines dichotomous regulation of T cell subsets in hypoxia. J Clin Invest. 2016;126:2678-88 pubmed publisher
  150. Ramos C, Savoldo B, Torrano V, Ballard B, Zhang H, Dakhova O, et al. Clinical responses with T lymphocytes targeting malignancy-associated ? light chains. J Clin Invest. 2016;126:2588-96 pubmed publisher
  151. van der Heiden M, van Zelm M, Bartol S, de Rond L, Berbers G, Boots A, et al. Differential effects of Cytomegalovirus carriage on the immune phenotype of middle-aged males and females. Sci Rep. 2016;6:26892 pubmed publisher
  152. Neumann B, Shi T, Gan L, Klippert A, Daskalaki M, Stolte Leeb N, et al. Comprehensive panel of cross-reacting monoclonal antibodies for analysis of different immune cells and their distribution in the common marmoset (Callithrix jacchus). J Med Primatol. 2016;45:139-46 pubmed publisher
  153. Contreras F, Prado C, Gonzalez H, Franz D, Osorio Barrios F, Osorio F, et al. Dopamine Receptor D3 Signaling on CD4+ T Cells Favors Th1- and Th17-Mediated Immunity. J Immunol. 2016;196:4143-9 pubmed publisher
  154. Stikvoort A, Sundin M, Uzunel M, Gertow J, Sundberg B, Schaffer M, et al. Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?. PLoS ONE. 2016;11:e0154737 pubmed publisher
  155. Yu C, Liu Y, Chan J, Tong J, Li Z, Shi M, et al. Identification of human plasma cells with a lamprey monoclonal antibody. JCI Insight. 2016;1: pubmed
  156. Reynaldi A, Smith N, Schlub T, Venturi V, Rudd B, Davenport M. Modeling the dynamics of neonatal CD8+ T-cell responses. Immunol Cell Biol. 2016;94:838-848 pubmed publisher
  157. Yamashita K, Kawata K, Matsumiya H, Kamekura R, Jitsukawa S, Nagaya T, et al. Bob1 limits cellular frequency of T-follicular helper cells. Eur J Immunol. 2016;46:1361-70 pubmed publisher
  158. Li H, Borrego F, Nagata S, Tolnay M. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells. J Immunol. 2016;196:4064-74 pubmed publisher
  159. Malkiel S, Jeganathan V, Wolfson S, Manjarrez Orduno N, Marasco E, Aranow C, et al. Checkpoints for Autoreactive B Cells in the Peripheral Blood of Lupus Patients Assessed by Flow Cytometry. Arthritis Rheumatol. 2016;68:2210-20 pubmed publisher
  160. Brown P, Gascoyne D, Lyne L, Spearman H, Felce S, McFadden N, et al. N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells. Haematologica. 2016;101:861-71 pubmed publisher
  161. Mohiuddin M, Singh A, Corcoran P, Thomas Iii M, Clark T, Lewis B, et al. Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft. Nat Commun. 2016;7:11138 pubmed publisher
  162. Rueda C, Presicce P, Jackson C, Miller L, Kallapur S, Jobe A, et al. Lipopolysaccharide-Induced Chorioamnionitis Promotes IL-1-Dependent Inflammatory FOXP3+ CD4+ T Cells in the Fetal Rhesus Macaque. J Immunol. 2016;196:3706-15 pubmed publisher
  163. Zwang N, Zhang R, Germana S, Fan M, Hastings W, Cao A, et al. Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3-Kinase and MEK Pathways. Am J Transplant. 2016;16:2624-38 pubmed publisher
  164. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  165. Flint S, Gibson A, Lucas G, Nandigam R, Taylor L, Provan D, et al. A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia. Haematologica. 2016;101:698-706 pubmed publisher
  166. Simon S, Vignard V, Florenceau L, Dreno B, Khammari A, Lang F, et al. PD-1 expression conditions T cell avidity within an antigen-specific repertoire. Oncoimmunology. 2016;5:e1104448 pubmed
  167. Liu L, Sommermeyer D, Cabanov A, Kosasih P, Hill T, Riddell S. Inclusion of Strep-tag II in design of antigen receptors for T-cell immunotherapy. Nat Biotechnol. 2016;34:430-4 pubmed publisher
  168. Klose D, Saunders U, Barth S, Fischer R, Jacobi A, Nachreiner T. Novel fusion proteins for the antigen-specific staining and elimination of B cell receptor-positive cell populations demonstrated by a tetanus toxoid fragment C (TTC) model antigen. BMC Biotechnol. 2016;16:18 pubmed publisher
  169. Ludigs K, Jandus C, Utzschneider D, Staehli F, Bessoles S, Dang A, et al. NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions. Nat Commun. 2016;7:10554 pubmed publisher
  170. Llibre A, López Macías C, Marafioti T, Mehta H, Partridge A, Kanzig C, et al. LLT1 and CD161 Expression in Human Germinal Centers Promotes B Cell Activation and CXCR4 Downregulation. J Immunol. 2016;196:2085-94 pubmed publisher
  171. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed publisher
  172. Su S, Hu B, Shao J, Shen B, Du J, Du Y, et al. CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients. Sci Rep. 2016;6:20070 pubmed publisher
  173. Lasigliè D, Boero S, Bauer I, Morando S, Damonte P, Cea M, et al. Sirt6 regulates dendritic cell differentiation, maturation, and function. Aging (Albany NY). 2016;8:34-49 pubmed
  174. Paris R, Petrovas C, Ferrando Martinez S, Moysi E, Boswell K, Archer E, et al. Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV Progression. PLoS ONE. 2015;10:e0144767 pubmed publisher
  175. Jabara H, Boyden S, Chou J, Ramesh N, Massaad M, Benson H, et al. A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency. Nat Genet. 2016;48:74-8 pubmed publisher
  176. Zhang Z, Wu N, Lu Y, Davidson D, Colonna M, Veillette A. DNAM-1 controls NK cell activation via an ITT-like motif. J Exp Med. 2015;212:2165-82 pubmed publisher
  177. Javed A, Leuchte N, Neumann B, Sopper S, Sauermann U. Noncytolytic CD8+ Cell Mediated Antiviral Response Represents a Strong Element in the Immune Response of Simian Immunodeficiency Virus-Infected Long-Term Non-Progressing Rhesus Macaques. PLoS ONE. 2015;10:e0142086 pubmed publisher
  178. Leong M, Newell E. Multiplexed Peptide-MHC Tetramer Staining with Mass Cytometry. Methods Mol Biol. 2015;1346:115-31 pubmed publisher
  179. Cox K, Tang A, Chen Z, Horton M, Yan H, Wang X, et al. Rapid isolation of dengue-neutralizing antibodies from single cell-sorted human antigen-specific memory B-cell cultures. MAbs. 2016;8:129-40 pubmed publisher
  180. Verma S, Weiskopf D, Gupta A, McDonald B, Peters B, Sette A, et al. Cytomegalovirus-Specific CD4 T Cells Are Cytolytic and Mediate Vaccine Protection. J Virol. 2016;90:650-8 pubmed publisher
  181. Newell K, Asare A, Sanz I, Wei C, Rosenberg A, Gao Z, et al. Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients. Am J Transplant. 2015;15:2908-20 pubmed publisher
  182. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed publisher
  183. Frederiksen J, Buggert M, Noyan K, Nowak P, Sönnerborg A, Lund O, et al. Multidimensional Clusters of CD4+ T Cell Dysfunction Are Primarily Associated with the CD4/CD8 Ratio in Chronic HIV Infection. PLoS ONE. 2015;10:e0137635 pubmed publisher
  184. Campi Azevedo A, Costa Pereira C, Antonelli L, Fonseca C, Teixeira Carvalho A, Villela Rezende G, et al. Booster dose after 10 years is recommended following 17DD-YF primary vaccination. Hum Vaccin Immunother. 2016;12:491-502 pubmed publisher
  185. Seror R, Nocturne G, Lazure T, Hendel Chavez H, Desmoulins F, Belkhir R, et al. Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren's syndrome: results of the BELISS study. Arthritis Res Ther. 2015;17:241 pubmed publisher
  186. Pearce V, Bouabe H, MacQueen A, Carbonaro V, Okkenhaug K. PI3Kδ Regulates the Magnitude of CD8+ T Cell Responses after Challenge with Listeria monocytogenes. J Immunol. 2015;195:3206-17 pubmed publisher
  187. Chen X, Li W, Zhang Y, Song X, Xu L, Xu Z, et al. Distribution of Peripheral Memory T Follicular Helper Cells in Patients with Schistosomiasis Japonica. PLoS Negl Trop Dis. 2015;9:e0004015 pubmed publisher
  188. Littwitz Salomon E, Akhmetzyanova I, Vallet C, Francois S, Dittmer U, Gibbert K. Activated regulatory T cells suppress effector NK cell responses by an IL-2-mediated mechanism during an acute retroviral infection. Retrovirology. 2015;12:66 pubmed publisher
  189. Schnorfeil F, Lichtenegger F, Emmerig K, Schlueter M, Neitz J, Draenert R, et al. T cells are functionally not impaired in AML: increased PD-1 expression is only seen at time of relapse and correlates with a shift towards the memory T cell compartment. J Hematol Oncol. 2015;8:93 pubmed publisher
  190. Li Y, Shen C, Zhu B, Shi F, Eisen H, Chen J. Persistent Antigen and Prolonged AKT-mTORC1 Activation Underlie Memory CD8 T Cell Impairment in the Absence of CD4 T Cells. J Immunol. 2015;195:1591-8 pubmed publisher
  191. Amos J, Himes J, Armand L, Gurley T, Martinez D, Colvin L, et al. Rapid Development of gp120-Focused Neutralizing B Cell Responses during Acute Simian Immunodeficiency Virus Infection of African Green Monkeys. J Virol. 2015;89:9485-98 pubmed publisher
  192. Pojero F, Flores Montero J, Sanoja L, Pérez J, Puig N, Paiva B, et al. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases. Cytometry B Clin Cytom. 2016;90:91-100 pubmed publisher
  193. Cimini E, Agrati C, D Offizi G, Vlassi C, Casetti R, Sacchi A, et al. Primary and Chronic HIV Infection Differently Modulates Mucosal Vδ1 and Vδ2 T-Cells Differentiation Profile and Effector Functions. PLoS ONE. 2015;10:e0129771 pubmed publisher
  194. Mathur R, Sehgal L, Braun F, Berkova Z, Romaguerra J, Wang M, et al. Targeting Wnt pathway in mantle cell lymphoma-initiating cells. J Hematol Oncol. 2015;8:63 pubmed publisher
  195. Kerkman P, Fabre E, van der Voort E, Zaldumbide A, Rombouts Y, Rispens T, et al. Identification and characterisation of citrullinated antigen-specific B cells in peripheral blood of patients with rheumatoid arthritis. Ann Rheum Dis. 2016;75:1170-6 pubmed publisher
  196. Boisson B, Laplantine E, Dobbs K, Cobat A, Tarantino N, Hazen M, et al. Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia. J Exp Med. 2015;212:939-51 pubmed publisher
  197. Tipton C, Fucile C, DARCE J, Chida A, Ichikawa T, Gregoretti I, et al. Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus. Nat Immunol. 2015;16:755-65 pubmed publisher
  198. McArthur M, Fresnay S, Magder L, Darton T, Jones C, Waddington C, et al. Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model. PLoS Pathog. 2015;11:e1004914 pubmed publisher
  199. Mahmood Z, Muhammad K, Schmalzing M, Roll P, Dörner T, Tony H. CD27-IgD- memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis. Arthritis Res Ther. 2015;17:61 pubmed publisher
  200. Pombo C, Wherry E, Gostick E, Price D, Betts M. Elevated Expression of CD160 and 2B4 Defines a Cytolytic HIV-Specific CD8+ T-Cell Population in Elite Controllers. J Infect Dis. 2015;212:1376-86 pubmed publisher
  201. Weinberg A, Muresan P, Richardson K, Fenton T, Domínguez T, Bloom A, et al. Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine. PLoS ONE. 2015;10:e0122431 pubmed publisher
  202. Castiello M, Scaramuzza S, Pala F, Ferrua F, Uva P, Brigida I, et al. B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2015;136:692-702.e2 pubmed publisher
  203. Inui M, Hirota S, Hirano K, Fujii H, Sugahara Tobinai A, Ishii T, et al. Human CD43+ B cells are closely related not only to memory B cells phenotypically but also to plasmablasts developmentally in healthy individuals. Int Immunol. 2015;27:345-55 pubmed publisher
  204. Claiborne D, Prince J, Scully E, Macharia G, Micci L, Lawson B, et al. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression. Proc Natl Acad Sci U S A. 2015;112:E1480-9 pubmed publisher
  205. Wensveen F, Jelenčić V, Valentić S, Šestan M, Wensveen T, Theurich S, et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat Immunol. 2015;16:376-85 pubmed publisher
  206. Severson J, Serracino H, Mateescu V, Raeburn C, McIntyre R, Sams S, et al. PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer. Cancer Immunol Res. 2015;3:620-30 pubmed publisher
  207. Sell S, Dietz M, Schneider A, Holtappels R, Mach M, Winkler T. Control of murine cytomegalovirus infection by γδ T cells. PLoS Pathog. 2015;11:e1004481 pubmed publisher
  208. Boyle M, Jagannathan P, Bowen K, McIntyre T, Vance H, Farrington L, et al. Effector Phenotype of Plasmodium falciparum-Specific CD4+ T Cells Is Influenced by Both Age and Transmission Intensity in Naturally Exposed Populations. J Infect Dis. 2015;212:416-25 pubmed publisher
  209. Lewis M, Vyse S, Shields A, Boeltz S, Gordon P, Spector T, et al. UBE2L3 polymorphism amplifies NF-κB activation and promotes plasma cell development, linking linear ubiquitination to multiple autoimmune diseases. Am J Hum Genet. 2015;96:221-34 pubmed publisher
  210. Rissiek A, Baumann I, Cuapio A, Mautner A, Kolster M, Arck P, et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun. 2015;58:12-20 pubmed publisher
  211. Dimova T, Brouwer M, Gosselin F, Tassignon J, Leo O, Donner C, et al. Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire. Proc Natl Acad Sci U S A. 2015;112:E556-65 pubmed publisher
  212. Funakoshi S, Shimizu T, Numata O, Ato M, Melchers F, Ohnishi K. BILL-cadherin/cadherin-17 contributes to the survival of memory B cells. PLoS ONE. 2015;10:e0117566 pubmed publisher
  213. de Masson A, Bouaziz J, Le Buanec H, Robin M, O Meara A, Parquet N, et al. CD24(hi)CD27⁺ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease. Blood. 2015;125:1830-9 pubmed publisher
  214. Johnson P, Challis R, Chowdhury F, Gao Y, Harvey M, Geldart T, et al. Clinical and biological effects of an agonist anti-CD40 antibody: a Cancer Research UK phase I study. Clin Cancer Res. 2015;21:1321-8 pubmed publisher
  215. Djukic M, Sostmann N, Bertsch T, Mecke M, Nessler S, Manig A, et al. Vitamin D deficiency decreases survival of bacterial meningoencephalitis in mice. J Neuroinflammation. 2015;12:208 pubmed publisher
  216. Laranjeira P, Pedrosa M, Pedreiro S, Gomes J, Martinho A, Antunes B, et al. Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells. Stem Cell Res Ther. 2015;6:3 pubmed publisher
  217. Krysiak K, Tibbitts J, Shao J, Liu T, Ndonwi M, Walter M. Reduced levels of Hspa9 attenuate Stat5 activation in mouse B cells. Exp Hematol. 2015;43:319-30.e10 pubmed publisher
  218. White C, Villarino N, Sloan S, Ganusov V, Schmidt N. Plasmodium suppresses expansion of T cell responses to heterologous infections. J Immunol. 2015;194:697-708 pubmed publisher
  219. Woda M, Mathew A. Fluorescently labeled dengue viruses as probes to identify antigen-specific memory B cells by multiparametric flow cytometry. J Immunol Methods. 2015;416:167-77 pubmed publisher
  220. Weihrauch M, Richly H, von Bergwelt Baildon M, Becker H, Schmidt M, Hacker U, et al. Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours. Eur J Cancer. 2015;51:146-56 pubmed publisher
  221. Van Eyck L, Hershfield M, Pombal D, Kelly S, Ganson N, Moens L, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135:283-7.e5 pubmed publisher
  222. Chovancová J, Bernard T, Stehlíková O, Sálek D, Janíková A, Mayer J, et al. Detection of Minimal Residual Disease in Mantle Cell Lymphoma. Establishment of Novel 8-Color Flow Cytometry Approach. Cytometry B Clin Cytom. 2014;: pubmed publisher
  223. Martin P, Dubois C, Jacquier E, Dion S, Mancini Bourgine M, Godon O, et al. TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice. Gut. 2015;64:1961-71 pubmed publisher
  224. Willmann K, Klaver S, DoÄŸu F, Santos Valente E, Garncarz W, Bilic I, et al. Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity. Nat Commun. 2014;5:5360 pubmed publisher
  225. Buchan S, Manzo T, Flutter B, Rogel A, Edwards N, Zhang L, et al. OX40- and CD27-mediated costimulation synergizes with anti-PD-L1 blockade by forcing exhausted CD8+ T cells to exit quiescence. J Immunol. 2015;194:125-133 pubmed publisher
  226. Mehta P, Nuotio Antar A, Smith C. γδ T cells promote inflammation and insulin resistance during high fat diet-induced obesity in mice. J Leukoc Biol. 2015;97:121-34 pubmed publisher
  227. McKinstry K, Strutt T, Bautista B, Zhang W, Kuang Y, Cooper A, et al. Effector CD4 T-cell transition to memory requires late cognate interactions that induce autocrine IL-2. Nat Commun. 2014;5:5377 pubmed publisher
  228. Neumann B, Klippert A, Raue K, Sopper S, Stahl Hennig C. Characterization of B and plasma cells in blood, bone marrow, and secondary lymphoid organs of rhesus macaques by multicolor flow cytometry. J Leukoc Biol. 2015;97:19-30 pubmed publisher
  229. van der Waart A, van de Weem N, Maas F, Kramer C, Kester M, Falkenburg J, et al. Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy. Blood. 2014;124:3490-500 pubmed publisher
  230. Spaan M, Kreefft K, de Graav G, Brouwer W, de Knegt R, ten Kate F, et al. CD4+ CXCR5+ T cells in chronic HCV infection produce less IL-21, yet are efficient at supporting B cell responses. J Hepatol. 2015;62:303-10 pubmed publisher
  231. Rasmussen S, Bilgrau A, Schmitz A, Falgreen S, Bergkvist K, Tramm A, et al. Stable Phenotype Of B-Cell Subsets Following Cryopreservation and Thawing of Normal Human Lymphocytes Stored in a Tissue Biobank. Cytometry B Clin Cytom. 2014;: pubmed publisher
  232. Kudernatsch R, Letsch A, Guerreiro M, Löbel M, Bauer S, Volk H, et al. Human bone marrow contains a subset of quiescent early memory CD8(+) T cells characterized by high CD127 expression and efflux capacity. Eur J Immunol. 2014;44:3532-42 pubmed publisher
  233. Toapanta F, Simon J, Barry E, Pasetti M, Levine M, Kotloff K, et al. Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans. Front Immunol. 2014;5:374 pubmed publisher
  234. Li Z, Li W, Li N, Jiao Y, Chen D, Cui L, et al. γδ T cells are involved in acute HIV infection and associated with AIDS progression. PLoS ONE. 2014;9:e106064 pubmed publisher
  235. Wei H, Nash W, Makrigiannis A, Brown M. Impaired NK-cell education diminishes resistance to murine CMV infection. Eur J Immunol. 2014;44:3273-82 pubmed publisher
  236. Davey M, Morgan M, Liuzzi A, Tyler C, Khan M, Szakmany T, et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol. 2014;193:3704-3716 pubmed publisher
  237. Della Torre E, Feeney E, Deshpande V, Mattoo H, Mahajan V, Kulikova M, et al. B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease. Ann Rheum Dis. 2015;74:2236-43 pubmed publisher
  238. Frencher J, Shen H, Yan L, Wilson J, Freitag N, Rizzo A, et al. HMBPP-deficient Listeria mutant immunization alters pulmonary/systemic responses, effector functions, and memory polarization of Vγ2Vδ2 T cells. J Leukoc Biol. 2014;96:957-67 pubmed publisher
  239. Lee Chang C, Bodogai M, Moritoh K, Olkhanud P, Chan A, Croft M, et al. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood. 2014;124:1450-9 pubmed publisher
  240. Lundell A, Johansen S, Adlerberth I, Wold A, Hesselmar B, Rudin A. High proportion of CD5+ B cells in infants predicts development of allergic disease. J Immunol. 2014;193:510-8 pubmed publisher
  241. Steinsbø Ø, Henry Dunand C, Huang M, Mesin L, Salgado Ferrer M, Lundin K, et al. Restricted VH/VL usage and limited mutations in gluten-specific IgA of coeliac disease lesion plasma cells. Nat Commun. 2014;5:4041 pubmed publisher
  242. Weston W, Zayas J, Perez R, George J, Jurecic R. Dynamic equilibrium of heterogeneous and interconvertible multipotent hematopoietic cell subsets. Sci Rep. 2014;4:5199 pubmed publisher
  243. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed publisher
  244. Demberg T, Mohanram V, Venzon D, Robert Guroff M. Phenotypes and distribution of mucosal memory B-cell populations in the SIV/SHIV rhesus macaque model. Clin Immunol. 2014;153:264-76 pubmed publisher
  245. Wilson E, Singh A, Hullsiek K, Gibson D, Henry W, Lichtenstein K, et al. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. J Infect Dis. 2014;210:1396-406 pubmed publisher
  246. Barbosa R, Silva S, Silva S, Melo A, Pereira Santos M, Barata J, et al. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency. J Clin Immunol. 2014;34:573-83 pubmed publisher
  247. Liu B, Cao Y, Huizinga T, Hafler D, Toes R. TLR-mediated STAT3 and ERK activation controls IL-10 secretion by human B cells. Eur J Immunol. 2014;44:2121-9 pubmed publisher
  248. Cartwright E, McGary C, Cervasi B, Micci L, Lawson B, Elliott S, et al. Divergent CD4+ T memory stem cell dynamics in pathogenic and nonpathogenic simian immunodeficiency virus infections. J Immunol. 2014;192:4666-73 pubmed publisher
  249. Cartellieri M, Koristka S, Arndt C, Feldmann A, Stamova S, von Bonin M, et al. A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells. PLoS ONE. 2014;9:e93745 pubmed publisher
  250. Kuwahara M, Suzuki J, Tofukuji S, Yamada T, Kanoh M, Matsumoto A, et al. The Menin-Bach2 axis is critical for regulating CD4 T-cell senescence and cytokine homeostasis. Nat Commun. 2014;5:3555 pubmed publisher
  251. Ito S, Bollard C, Carlsten M, Melenhorst J, Biancotto A, Wang E, et al. Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers. Mol Ther. 2014;22:1388-1395 pubmed publisher
  252. Le Saout C, Hasley R, Imamichi H, Tcheung L, Hu Z, Luckey M, et al. Chronic exposure to type-I IFN under lymphopenic conditions alters CD4 T cell homeostasis. PLoS Pathog. 2014;10:e1003976 pubmed publisher
  253. Peguillet I, Milder M, Louis D, Vincent Salomon A, Dorval T, Piperno Neumann S, et al. High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer. Cancer Res. 2014;74:2204-16 pubmed publisher
  254. Sereti I, Estes J, Thompson W, Morcock D, Fischl M, Croughs T, et al. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS Pathog. 2014;10:e1003890 pubmed publisher
  255. Chang S, Kohrt H, Maecker H. Monitoring the immune competence of cancer patients to predict outcome. Cancer Immunol Immunother. 2014;63:713-9 pubmed publisher
  256. Guan S, Liu J, Fang E, Ng T, Lian Y, Ge H. Chronic unpredictable mild stress impairs erythrocyte immune function and changes T-lymphocyte subsets in a rat model of stress-induced depression. Environ Toxicol Pharmacol. 2014;37:414-22 pubmed publisher
  257. Doi H, Tanoue S, Kaplan D. Peripheral CD27-CD21- B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosis. Clin Immunol. 2014;150:184-91 pubmed publisher
  258. Cairo C, Longinaker N, Cappelli G, Leke R, Ondo M, Djokam R, et al. Cord blood V?2V?2 T cells provide a molecular marker for the influence of pregnancy-associated malaria on neonatal immunity. J Infect Dis. 2014;209:1653-62 pubmed publisher
  259. Park S, Veerapu N, Shin E, Biancotto A, McCoy J, Capone S, et al. Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection. Nat Med. 2013;19:1638-42 pubmed publisher
  260. te Raa G, Pascutti M, Garcia Vallejo J, Reinen E, Remmerswaal E, ten Berge I, et al. CMV-specific CD8+ T-cell function is not impaired in chronic lymphocytic leukemia. Blood. 2014;123:717-24 pubmed publisher
  261. Lutwama F, Kagina B, Wajja A, Waiswa F, Mansoor N, Kirimunda S, et al. Distinct T-cell responses when BCG vaccination is delayed from birth to 6 weeks of age in Ugandan infants. J Infect Dis. 2014;209:887-97 pubmed publisher
  262. Chopra M, Lang I, Salzmann S, Pachel C, Kraus S, Bäuerlein C, et al. Tumor necrosis factor induces tumor promoting and anti-tumoral effects on pancreatic cancer via TNFR1. PLoS ONE. 2013;8:e75737 pubmed publisher
  263. Parzych E, Li H, Yin X, Liu Q, Wu T, Podsakoff G, et al. Effects of immunosuppression on circulating adeno-associated virus capsid-specific T cells in humans. Hum Gene Ther. 2013;24:431-42 pubmed publisher
  264. Canary L, Vinton C, Morcock D, Pierce J, Estes J, Brenchley J, et al. Rate of AIDS progression is associated with gastrointestinal dysfunction in simian immunodeficiency virus-infected pigtail macaques. J Immunol. 2013;190:2959-65 pubmed publisher
  265. Manjarrez Orduno N, Marasco E, Chung S, Katz M, Kiridly J, Simpfendorfer K, et al. CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation. Nat Genet. 2012;44:1227-30 pubmed publisher
  266. Kobie J, Alcena D, Zheng B, Bryk P, Mattiacio J, Brewer M, et al. 9G4 autoreactivity is increased in HIV-infected patients and correlates with HIV broadly neutralizing serum activity. PLoS ONE. 2012;7:e35356 pubmed publisher
  267. Kobie J, Zheng B, Bryk P, Barnes M, Ritchlin C, Tabechian D, et al. Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor. Arthritis Res Ther. 2011;13:R209 pubmed publisher
  268. Randall K, Chan S, Ma C, Fung I, Mei Y, Yabas M, et al. DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice. J Exp Med. 2011;208:2305-20 pubmed publisher
  269. Crawford T, Ndhlovu L, Tan A, Carvidi A, Hecht F, Sinclair E, et al. HIV-1 infection abrogates CD8+ T cell mitogen-activated protein kinase signaling responses. J Virol. 2011;85:12343-50 pubmed publisher
  270. Li H, Lasaro M, Jia B, Lin S, Haut L, High K, et al. Capsid-specific T-cell responses to natural infections with adeno-associated viruses in humans differ from those of nonhuman primates. Mol Ther. 2011;19:2021-30 pubmed publisher
  271. Cairo C, Armstrong C, Cummings J, Deetz C, Tan M, Lu C, et al. Impact of age, gender, and race on circulating ?? T cells. Hum Immunol. 2010;71:968-75 pubmed publisher
  272. Brucklacher Waldert V, Steinbach K, Lioznov M, Kolster M, Holscher C, Tolosa E. Phenotypical characterization of human Th17 cells unambiguously identified by surface IL-17A expression. J Immunol. 2009;183:5494-501 pubmed publisher
  273. Contreras X, Schweneker M, Chen C, McCune J, Deeks S, Martin J, et al. Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells. J Biol Chem. 2009;284:6782-9 pubmed publisher
  274. Cummings J, Cairo C, Armstrong C, Davis C, Pauza C. Impacts of HIV infection on Vgamma2Vdelta2 T cell phenotype and function: a mechanism for reduced tumor immunity in AIDS. J Leukoc Biol. 2008;84:371-9 pubmed publisher
  275. Sridhar S, Reyes Sandoval A, Draper S, Moore A, Gilbert S, Gao G, et al. Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron A. J Virol. 2008;82:3822-33 pubmed publisher
  276. Badovinac V, Harty J. Manipulating the rate of memory CD8+ T cell generation after acute infection. J Immunol. 2007;179:53-63 pubmed
  277. Wei C, Anolik J, Cappione A, Zheng B, Pugh Bernard A, Brooks J, et al. A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J Immunol. 2007;178:6624-33 pubmed
  278. Infantino S, Moepps B, Thelen M. Expression and regulation of the orphan receptor RDC1 and its putative ligand in human dendritic and B cells. J Immunol. 2006;176:2197-207 pubmed
  279. Crough T, Burrows J, Fazou C, Walker S, Davenport M, Khanna R. Contemporaneous fluctuations in T cell responses to persistent herpes virus infections. Eur J Immunol. 2005;35:139-49 pubmed
  280. Viguier M, Lemaitre F, Verola O, Cho M, Gorochov G, Dubertret L, et al. Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol. 2004;173:1444-53 pubmed
  281. Pace K, Lee C, Stewart P, Baum L. Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1. J Immunol. 1999;163:3801-11 pubmed